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ABSTRACT OF THE DISSERTATION 
CHARACTERIZATION OF RECOMBINANT CHLOROPEROXIDASE, AND F103A 
AND C29H/C79H/C87H MUTANTS 
by 
Zheng Wang 
Florida International University, 2011 
Miami, Florida 
Professor Xiaotang Wang, Major Professor 
Mechanistically and structurally chloroperoxidase (CPO) occupies a unique niche 
among heme containing enzymes. Chloroperoxidase catalyzes a broad range of reactions, 
such as oxidation of organic substrates, dismutation of hydrogen peroxide, and 
mono-oxygenation of organic molecules. To expand the synthetic utility of CPO and to 
appreciate the important interactions that lead to CPO’s exceptional properties, a 
site-directed mutagenesis study was undertaken.  
Recombinant CPO and CPO mutants were heterologously expressed in Aspergillus 
niger. The overall protein structure was almost the same as that of wild type CPO, as 
determined by UV-vis, NMR and CD spectroscopies. Phenylalanine103, which was 
proposed to regulate substrate access to the active site by restricting the size of substrates 
and to control CPO’s enantioselectivity, was mutated to Ala. The ligand binding affinity 
and most importantly the catalytic activity of F103A was dramatically different from wild 
type CPO. The mutation essentially eliminated the chlorination and dismutation activities 
but enhanced, 4-10 fold, the epoxidation, peroxidation, and N-demethylation activities. 
As expected, the F103A mutant displayed dramatically improved epoxidation activity for  
 
 
vii 
 
larger, more branched styrene derivatives. Furthermore, F103A showed a distinctive 
enantioselectivity profile: losing enantioselectivity to styrene and cis-β-methylstyrene; 
having a different configuration preference on α-methylstyrene; showing higher 
enatioselectivites and conversion rates on larger, more branched substrates. Our results 
show that F103 acts as a switch box that controls the catalytic activity, substrate 
specificity, and product enantioselectivity of CPO. Given that no other mutant of CPO 
has displayed distinct properties, the results with F103A are dramatic. 
The diverse catalytic activity of CPO has long been attributed to the presence of the 
proximal thiolate ligand. Surprisingly, a recent report on a C29H mutant suggested 
otherwise. A new CPO triple mutant C29H/C79H/C87H was prepared, in which all the 
cysteines were replaced by histidine to eliminate the possibility of cysteine coordinating 
to the heme. No active form protein was isolated, although, successful transformation and 
transcription was confirmed. The result suggests that Cys79 and Cys87 are critical to 
maintaining the structural scaffold of CPO. 
In vitro biodegradation of nanotubes by CPO were examined by scanning electron 
microscope method, but little oxidation was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
TABLE OF CONTENTS 
CHAPTER                                                         PAGE 
I Introduction ................................................................................................................ 1 
1.1 Background ....................................................................................................... 1 
1.2 Chloroperoxidase structure and reaction mechanism ....................................... 4 
1.2.1 Chloroperoxidase reaction mechanism ...................................................... 4 
1.2.2 Structure of CPO ........................................................................................ 8 
1.3 Heterologous CPO expression ........................................................................ 15 
1.3.1 Aspergillus niger expression system ........................................................ 16 
1.3.2 Factors that affect CPO expression in Aspergillus niger .......................... 20 
1.4 Objectives of this work ................................................................................... 25 
 
II Optimization of Aspergillus niger expression system and NMR study of 
recombinant CPO ..................................................................................................... 26 
2.1 Material and methods ...................................................................................... 26 
2.1.1 Strains and reagents .................................................................................. 26 
2.1.2 Genomic DNA extraction and sequencing ............................................... 26 
2.1.3 Expression of rCPO .................................................................................. 27 
2.1.4 Purification of rCPO ................................................................................. 27 
2.1.5 Western blotting procedure ....................................................................... 28 
2.1.6 Circular Dichroism spectrum study .......................................................... 28 
2.1.7 UV-visible absorption spectrum study ..................................................... 28 
2.1.8 Enzyme activity Assays ............................................................................ 29 
2.1.9 NMR spectroscopy ................................................................................... 29 
2.2 Results and discussion .................................................................................... 30 
2.2.1 Optimization of rCPO production and purification procedure for rCPO . 30 
2.2.2 Validation of rCPO ................................................................................... 35 
2.2.3 UV-vis & CD spectroscopic study of rCPO ............................................. 37 
2.2.4 NMR spectroscopic study of rCPO .......................................................... 38 
2.3. Conclusion ..................................................................................................... 48 
 
III F103A CPO mutant preparation and properties ....................................................... 50 
3.1 Material and methods ...................................................................................... 50 
3.1.1 Strains and reagents .................................................................................. 50 
3.1.2 CPO mutant gene construction ................................................................. 50 
3.1.3 Plasmid transformation into Aspergillus niger protoplast ........................ 51 
3.1.4 Genomic DNA extraction and sequencing ............................................... 52 
3.1.5 Expression of F103A mutant .................................................................... 52 
3.1.7 Western blotting procedure ....................................................................... 53 
3.1.8 Circular Dichroism spectum study ........................................................... 53 
3.1.9 UV-Visible absorption spectrum study ..................................................... 53 
3.1.10 Determination of extinction coefficients of CPO mutant ....................... 53 
3.1.11 Activity assays ........................................................................................ 54 
 
 
ix 
 
3.1.12 Optimum pH for the chlorination activity .............................................. 56 
3.1.13 Ligand binding study .............................................................................. 56 
3.2. Results and discussion ................................................................................... 57 
3.2.1 Preparation and purification of F103A mutant ......................................... 57 
3.2.2 Structure and function study of F103A mutant ........................................ 61 
3.2.3 F103A mutant as a possible industrial catalyst ........................................ 76 
3.3 Conclusion ...................................................................................................... 82 
 
IV C29H/C79H/C87H CPO mutant purification and characterization ......................... 85 
4.1 Material and methods ...................................................................................... 85 
4.1.1 Strains and reagents .................................................................................. 85 
4.1.2 CPO mutant gene construction of expression plasmid ............................. 85 
4.1.3 Plasmid transformation into Aspergillus niger protoplast ........................ 85 
4.1.4 Genomic DNA extraction and sequencing ............................................... 85 
4.1.5 Expression of C29H/C79H/C87H CPO mutant ....................................... 86 
4.1.6 Total mRNA extraction and reverse transcription PCR ........................... 86 
4.1.7 Western blotting procedures ..................................................................... 86 
4.2 Results and discussion .................................................................................... 86 
4.3 Conclusion ...................................................................................................... 89 
 
V In vitro biodegradation of carbon nanotube by CPO ................................................ 91 
5.1 Material and methods ...................................................................................... 91 
5.1.1 Reagents ................................................................................................... 91 
5.1.2 Nanotube biodegradation by CPO and H2O2 ........................................... 91 
5.1.3 Measurement of H2O2 concentration ........................................................ 92 
5.1.4 Scanning slectron microscope (SEM) ...................................................... 92 
5.2 Results and discussion .................................................................................... 92 
5.3 Conclusion ...................................................................................................... 93 
 
VI Perspectives .............................................................................................................. 96 
 
REFERENCES ................................................................................................................. 96 
 
APPENDICES ................................................................................................................ 105 
 
VITA ............................................................................................................................... 112 
  
  
 
 
x 
 
LIST OF TABLES 
TABLE                                                            PAGE 
2.1 Optimized condition for production of rCPO after 72 h culture .............................. 31 
2.2 Purification result of rCPO from A. niger culture .................................................... 35 
2.3 Spin lattice relaxation times (T1) of paramagnetic shifted resonances for rCPO  
and Wt CPO in 0.1 M phosphate buffer, pD 5.5 and 25 °C ..................................... 47 
2.4 Distance between the selected protons and the heme iron in rCPO based  
upon spin-lattice relaxation values and from the X-ray structure of Wt CPO ......... 48 
 
3.1 F103A purification result ......................................................................................... 59 
3.2 Spectral properties of heme thiolate proteins (P450cam, Wt CPO and F103A) 
and their ligand complexes ....................................................................................... 64 
 
3.3 Optical absorption data, dissociation constants, and spin states of ferric  
Wt CPO & ferric F103A ligand complexes .............................................................. 73 
 
3.4 Apparent Kd for cyanide binding of Wt CPO and F103A at various pH ................. 74 
3.5 Enantioselectivity study of F103A catalyzed of epoxidation reactions ................... 81 
  
 
 
xi 
 
LIST OF FIGURES 
FIGURE                                                           PAGE 
1.1 Typical non-halogenating oxidation reactions catalyzed by CPO from C. fumago ... 3 
 
1.2 Cpd I formation from ferric hydrogen peroxide (Fe-HOOH) via Cpd 0 .................... 5 
1.3 Structures of a variety of intermediates formed during CPO catalyzed reactions ..... 8 
1.4 Chloroperoxidase crystal structure (complex with Mn2+) ......................................... 9 
1.5 cis-β-methylstyrene docked in the substrate pocket of CPO .................................... 12 
1.6 The active center of CPO ......................................................................................... 14 
1.7 The chromosomal integration of vector DNA into Aspergillus ................................ 18 
1.8 The expression vector for co-transformation of A. niger ......................................... 21 
1.9 The secretion pathway in filamentous fungi ............................................................ 23 
2.1 rCPO production yields versus days after inoculation ............................................. 33 
2.2 Chromatogram of ion exchange chromatography of rCPO ...................................... 34 
2.3 Chromatogram of gel filtration chromatography of rCPO ....................................... 35 
2.4 12% SDS-PAGE result of rCPO purification ........................................................... 36 
2.5 Western blotting results of Wt CPO and rCPO ........................................................ 36 
 
2.6 UV-vis spectra of rCPO and Wt CPO in 50 mM phosphate buffer, pH 5.0 ............. 37 
2.7 The CD spectra of rCPO (0.4 µM in 10 mM phosphate buffer, pH=6) and  
Wt CPO (0.35 µM in 10 mM phosphate buffer, pH=6) ........................................... 38 
 
2.8 NMR spectrum of rCPO at 25 °C in 0.1 M potassium phosphate buffer ................. 41 
2.9 Selected signals from the NMR spectra of rCPO at various relaxation times at 
25ºC and pD 5.5 ........................................................................................................ 42 
 
2.10 Determination of the spin-lattice relation times from peak intensities versus  
delay times ................................................................................................................ 43 
 
 
xii 
 
2.11 Curie plots for selected signals of rCPO .................................................................. 44 
2.12 rCPO COSY plot and crosspeak assignments based on analogy with  
Wt CPO .................................................................................................................... 45 
2.13 rCPO NOESY plot and crosspeak assignments based on analogy with  
Wt CPO .................................................................................................................... 46 
3.1 Chromatogram of ion exchange chromatography of F103A. ................................... 58 
3.2 Chromatogram of gel filtration chromatography of F103A ..................................... 58 
3.3 Visible spectra of the free ferrous heme-pyridine complex of F103A and 
Wt CPO .................................................................................................................... 59 
3.4 15% SDS-PAGE result of F103A purification ......................................................... 60 
3.5 Western blotting analysis results of F103A, Wt CPO and rCPO ............................. 60 
3.6 UV-vis spectra of Wt CPO, and F103A in 0.05 M potassium phosphate buffer,  
pH 5.0, and P450 camphor in 0.05 M potassium phosphate buffer, pH 7.4 ............. 63 
3.7 UV-vis spectra of the ferric, ferrous, and ferrous-CO complexes of the F103A 
in 0.05 M potassium phosphate buffer, pH 5.0 ......................................................... 63 
3.8 The CD spectra of F103A (0.375 µM in 10 mM phosphate buffer, pH=6) and  
Wt CPO (0.3 µM in 10 mM phosphate buffer, pH=6) ............................................. 65 
3.9 Relative activities of Wt CPO, C29H, F103A and E183H mutants ......................... 65 
3.10 Catalase activity assays of Wt CPO and F103A. ...................................................... 66 
3.11 N-demethylation activity comparison between Wt CPO and F103A ....................... 66 
3.12 UV-vis spectra of F103A mutant in 0.1 M potassium phosphate buffer at pH 3 ..... 69 
3.13 UV-vis spectra of the cyanide complexes of ferric Wt CPO and F103A ................. 70 
3.14 UV-vis spectra of the azide complexes of ferric Wt CPO and F103A ..................... 70 
3.15 UV-vis spectra of the imidazole complexes of ferric Wt CPO and F103A .............. 71 
3.16 UV-vis spectra of the thiocyanate complexes of ferric Wt CPO and F103A ........... 71 
3.17 UV-vis spectra of the formate complexes of ferric Wt CPO and F103A ................. 72 
 
 
xiii 
 
3.18 UV-vis spectra of the acetate complexes of ferric Wt CPO and F103A .................. 72 
3.19 pH profiles for chlorination activity of Wt CPO and F103A ................................... 75 
3.20 UV absorbance decrease at 242 nm profiles for F103A (39 nM) catalysis of the 
epoxidation of α-methylstyrene, α-ethylstyrene, and α-propylstyrene (300 µM) 
in 100 mM citrate buffer, pH = 5.5 ........................................................................... 77 
 
3.21 UV absorbance decrease at 243 nm profiles for F103A (39 nM) catalysis of the 
epoxidation of 2-methyl-phenyl-1-propene and 1,2-dimethyl-propenyl-benzene  
(300 µM) in 100 mM citrate buffer, pH = 5.5 .......................................................... 78 
 
3.22 UV absorbance decrease at 250 nm profiles for F103A (39 nM) catalysis of  
the epoxidation of trans-β-methylstyrene, trans-1-phenyl-1-butene, and 
trans-1-phenyl-1-pentene (300 µM) in 100 mM citrate buffer, pH = 5.5 ................. 78 
 
3.23 Chiral HPLC trace of the products obtained from the epoxidation of styrene 
catalyzed by Wt CPO ............................................................................................... 80 
 
3.24 Chiral HPLC trace of the products obtained from the epoxidation of styrene 
catalyzed by F103A. ................................................................................................. 81 
 
4.1 Confirmation of positive transformation and transcription of  
C29H/C79H/C87H mutant ....................................................................................... 88 
4.2 Western blotting analysis on extracted both cellular and extracellular protein 
samples from A. niger strain (ATCC 62590) transformed with CPO expression 
vector pCPO#3C to detect CPO mutant expression ................................................. 89 
 
5.1 SEM images of SWNTs treated with CPO for 8 weeks ........................................... 93 
  
 
 
xiv 
 
LIST OF ABBREVIATIONS 
ABBREVIATION FULL NAME 
Aa Amino acid 
ABTS 2,2'-azino-bis-3-ethyl-benzthiazoline-6-sulfonic acid 
ALA δ-Aminolevulinic Acid 
A.niger Aspergillus niger 
ATCC American type culture collection 
BSA Bovine serum ablumin 
BHT  Butylated hydroxytoluene 
C. fumago Caldariomyces fumago 
CD  Circular Dichroism  
COSY  Correlation spectroscopy 
CPD Cyclopentanedione 
Cpd 0 Compound 0 
Cpd I Compound I 
Cpd II Compound II 
Cpd X Compound X 
CPO Chloroperoxidase 
DNA Deoxyribonucleic acid 
DMF N,N-dimethylformamide 
ee% Enantiomeric excess 
ER Endoplasmic reticulum 
 
 
xv 
 
ε Extinction coefficient 
E. coli Escherichia coli 
F103A CPO with F103 to A mutation 
GLA Glucoamylase 
HPLC High-performance liquid chromatography 
HRP Horseradish peroxidase 
MCD Monochlorodimedone 
Mnp Manganese peroxidase 
rMnp Recombinant manganese peroxidase  
NMR Nuclear magnetic resonance spectroscopy 
NOESY Nuclear overhauser enhancement spectroscopy 
P450 Cytochrome P450  
P450cam P450 camphor 
PCR Polymerase chain reaction 
rCPO Recombinant CPO 
RNA Ribonucleic acid 
RT PCR Reverse transcription PCR 
Rz value Reinheitzahl value 
ROS Reactive oxygen species  
SWNTs Single-walled nanotubes 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM Scanning electron microscope 
 
 
xvi 
 
T1 Spin-lattice relation time 
TBST buffer Tris buffered saline with tween buffer 
UV-vis Ultraviolet-visible 
Wt CPO Wild type CPO 
 
 
 
1 
 
Chapter I 
Introduction 
1.1 Background  
Chloroperoxidase (CPO, EC 1.11.1.10) was originally isolated by Morris and Hager 
from the marine filamentous fungus, Caldariomyces fumago (C. fumago) in 1966 (Hager, 
Morris et al. 1966; Morris and Hager 1966; Brown and Hager 1967), as the enzyme 
responsible for the halogenations of caldariomycin, an antibiotic secreted by C. fumago. 
Chloroproxidase is a heavily glycosylated monomeric hemeprotein with carbohydrates 
accounting for 19% ~25% of the total molecular weight and one ferriprotoporphyrin IX 
prosthetic group per enzyme molecule (Hallenberg and Hager 1978). Chloroperoxidase 
derives its catalytic activity from its heme prosthetic group, and has a Soret band with an 
absorbance maximum at 398 nm and an extinction coefficient of 9.10×104 M-1cm-1 
(Hallenberg and Hager 1978). Initially, two isoforms with molecular weights of 
approximately 42 and 46 kDa were reported, but later work found additional isoforms 
that also differed in their carbohydrate content (Kenigsberg, Fang et al. 1987). The pH 
optimum for chlorination and the isoelectric point (pI) were determined to be 2.7 and 4 
respectively (Makino, Chiang et al. 1976).  
Chloroperoxidase occupies a key position amongst heme containing proteins, and it 
is the most versatile and efficient enzyme within the heme-peroxidase family. In addition 
to peroxide dependent halogenations (Thomas and Hager 1968; Thomas, Morris et al. 
1970), CPO is also able to catalyze a broad spectrum of reactions (Thomas, Morris et al. 
1970; Hofrichter and Ullrich 2006), including the typical peroxidase reactions, catalase 
reactions (Thomas, Morris et al. 1970), some P450-like oxidation reactions (Hollenberg 
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and Hager 1973), as outlined in scheme 1.1. Site directed mutagenesis of CPO offers the 
possibility of determining residues important for the catalase, cytochrome P450 
mono-oxygenase, and peroxidase activities of CPO, and the potential of elucidating the 
relationship between these diverse activities.  
 
RH + H2O2 + X- + H+ R−X + 2H2O              (1) 
2RH + H2O2 R−R + 2H2O                             (2) 
2H2O2 O2 + 2H2O                                       (3) 
R + H2O2 R−O + H2O                                  (4) 
Scheme 1.1 Halogenase, peroxidase, catalase, and mono-oxygenase types of reactions 
catalyzed by CPO are given in Equations 1→4, respectively. E represents the resting 
form of enzyme CPO; both RH and R represent substrates; X- is the halide ions. 
 
 In addition, CPO has the potential to catalyze the synthesis of a wide range of chiral 
or prochiral products. Chloroperoxidase can catalyze many reactions that are important in 
synthesis such as sulfoxidation (Silverstein and Hager 1974; Doerge 1986), hydroxylation 
(Miller, Tschirret-Guth et al. 1995) and epoxidation (Geigert, Lee et al. 1986), 
enantioselectivly and in high yield (Casella, Poli et al. 1994; Lakner and Hager 1996), 
such as the epoxidation of olefins (Ortiz de Montellano, Choe et al. 1987), where 
traditional peroxidases have failed. Other reactions such as N-demethylation (Kedderis, 
Koop et al. 1980) and dehalogenation (Osborne, Raner et al. 2006) are also possible. 
Some selected non-halogenating oxidation reactions catalyzed by CPO are listed in fig. 
1.1. Unlike P450, CPO can catalyze these reactions without cofactors like NAD(P)H, 
which are difficult to recover and recycle in industry; other peroxidases and catalases 
catalyze these reactions very slowly, if it all. 
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Figure 1.1 Typical non-halogenating oxidation reactions catalyzed by CPO from C. 
fumago. The figure was copied from Ullrich et al (Hofrichter and Ullrich 2006). 1. 
N-dealkylation, e.g. N,N-dimethylaniline to N-methylaniline; 2. oxidation of an amine to 
the corresponding N-oxide, e.g. p-chloroaniline; 3. enantioselective sulfoxidation of 
thioethers, e.g. thioanisole to (R)-methylphenylsulfoxide; 4.oxidation of indole to 
oxindole; 5. epoxidation / hydroxylation of 1,2-dihydronaphthalene; 6. hydroxylation of a 
propargyl group; 7a. hydroxylation of p-methylanisole; and 7b. sequential oxidation of 
one methyl group in p-xylene to the carboxylic acid.  
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 Chloroperoxidase, however, suffers from two drawbacks as a choice of catalyst for 
industrial uses: CPO is able to accept only a few substrates and has limited stability under 
catalytic conditions. Generally, substrates with at most nine carbon atoms, or equivalent 
are accepted (Hofrichter and Ullrich 2006). The limited stability is because of a 
self-destructive reaction with hydrogen peroxide, which is problematic for slow reactions, 
including hydroxylations (Miller, Tschirret-Guth et al. 1995) and epoxidations (Hager, 
Lakner et al. 1998). It is possible that site-directed mutagenesis and protein engineering 
will help to overcome these shortcomings. 
1.2 Chloroperoxidase structure and reaction mechanism 
1.2.1 Chloroperoxidase reaction mechanism 
 Reactions catalyzed by CPO can be classified into four categories. The first is 
halogenation reactions, which utilize three substrates: hydrogen peroxide or other 
hydroperoxides, halide ions except fluoride, and a wide range of suitable substrates 
(Corbett, Chipko et al. 1980). The second is the classic peroxidase reactions with a 
substrate and hydrogen peroxide, but without a halide ion. In the absence of a halide ion 
and organic substrate, CPO can catalyze reactions as a catalase: the disproportionation of 
hydrogen peroxide into dioxygen and water. Lastly, CPO shares some catalytic activities 
with cytochrome P450, such as mono-oxygenase reactions (Geigert, Neidleman et al. 
1983). 
 In the resting state, CPO has a ferric protoporphyrin IX in its active site. The ferric 
center then reacts with peroxide to form a short-lived intermediate, termed as “compound 
0” (Cpd 0). Heterolytic cleavage of the O-O bond in the loosely bound hydrogen 
peroxide molecule of Cpd 0 results in the formation of Compound I (Cpd I) and one 
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molecule of water (Penner-Hahn, McMurry et al. 1983; Frew and Jones 1984; 
Penner-Hahn, Smith Eble et al. 1986; Kim, Perera et al. 2006; Denisov, Dawson et al. 
2007), as showed in Fig 1.2.  
 
 
 
Figure 1.2 Cpd I formation from ferric hydrogen peroxide (Fe-HOOH) via Cpd 0. 
 
Compound I is a typical intermediate of many heme peroxidases, and its structure is 
an oxo-ferryl porphyrin cation-radical complex [heme (Fe4+=O)·+] (Kobayashi, Nakano et 
al. 1987). It is widely accepted that the formation of Cpd I is the first step for all the 
reactions that CPO catalyzes (Libby and Rotberg 1990; Green, Dawson et al. 2004). 
Although Cpd I of CPO is short-lived (Araiso, Rutter et al. 1981), it is the only Cpd I of a 
thiolate-ligated heme enzymes that is well characterized by many spectroscopic methods 
including UV-vis absorption, EPR, Mossbauer, and resonance Raman (Palcic, Rutter et al. 
1980; Sono, Eble et al. 1985; Hosten, Sullivan et al. 1994). Since CPO and P450 share 
the same proximal thiolate ligand, they also have many spectroscopic similarities. 
Therefore, the information from Cpd I of CPO may be relevant to the putative and elusive 
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P450 Cpd I species. The basic pathways of CPO-catalyzed reactions are summarized in 
Scheme 1.2. 
 
E + H2O2 Cpd I + H2O                            (1) 
Cpd I + RH Cpd II + R· + H+               (2) 
Cpd II + R·+ H+ +RH E + R−R + H2O (3) 
Cpd I + H2O2 E + O2 + H2O                     (4) 
Cpd I + R E + R−O                                  (5) 
Cpd I + X- Cpd X                                     (6) 
Cpd X + H+ E + H−OX                            (7) 
H−OX + RH R−X+ H2O                         (8) 
Cpd X + X-+ 2H+ E + X2 + H2O              (9) 
 
Scheme 1.2 Pathways of basic reactions catalyzed by CPO are listed in Equations 1 to 7. 
Cpd I, Cpd II, and Cpd X are the enzymatic cation radical intermediate compound I, 
reduced intermediate compound II, and electrophilic halogenation intermediate 
compound X, respectively. Eqn. 1 CPO reacts rapidly with H2O2 to form Cpd I, this is the 
initial step in all CPO catalyzed reactions. Eqn. 2 & 3 completes the classic peroxidase 
reaction. Eqn. 4 is the catalase reaction. Eqn. 5 is the mono-oxygenase reaction. Eqn. 6 is 
the initiation step of the halide dependent reactions. Eqn. 7 & 8 completes the normal 
halogenation pathway. Finally, Eqn. 9 is the pathway for formation of molecular halogen. 
It should be noted that a variety of organic hydroperoxides ( ROOH’s ) or peroxy acids 
can replace H2O2 in reactions. 
 
In the peroxidase mode, Cpd I abstracts a hydrogen atom from an organic substrate 
(RH) to produce an organic radical (R·), and in the process Cpd I is converted to Cpd II, 
which is assumed to be a FeIV=O (Green, Dawson et al. 2004; Stone, Behan et al. 2006). 
The reaction involves a one-electron transfer. The intermediate Cpd II then oxidizes 
another substrate molecule to return to the ferric resting state (Nakajima, Yamazaki et al. 
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1985; Terner, Palaniappan et al. 2006; Gebicka and Didik 2007). Again a one-electron 
transfer reaction. CPO catalyzes the dehalogenation reaction using a similar mechanism 
(Zhang, Nagraj et al. 2006). 
 In the catalase mode, Cpd I reacts with a second molecule of hydrogen peroxide, in a 
two electron process, to produce dioxygen and the resting ferric state of the heme iron 
(Araiso, Rutter et al. 1981; Sun, Kadima et al. 1994). 
 In halogenase mode, Cpd I reacts with a halogen ion to form compound X (Cpd X), 
then Cpd X reacts with the substrate or water, either generating a chlorinated product 
(Champion, Munck et al. 1973; Suh and Hager 1991) or HOX, respectively (Libby, 
Shedd et al. 1992). The HOX can also oxidize organic molecules. The dual mechanism of 
halogenations is proposed to explain the general lack of enantioselectivity during 
halogenation reactions catalyzed by CPO. Compound X can react with a variety of 
substrates to perform halogen dependent peroxidatic, catalatic, and peroxygenase 
reactions (Dunford, Lambeir et al. 1987; Kobayashi, Nakano et al. 1987; Aaronson, 
Hager et al. 1988; Libby, Rotberg et al. 1989). Cpd X can also react with a halogen ion to 
form molecular halogen. 
 In the mono-oxygenase mode, Cpd I reacts directly with the substrate in a 
two-electron process, this is the underlying mechanism for a variety of reactions that 
CPO catalyzes, such as mono-oxygenation (Geigert, Lee et al. 1986; Ortiz de Montellano, 
Choe et al. 1987; Horner, Mouesca et al. 2007), hydroxylation (Miller, Tschirret-Guth et 
al. 1995), sulfoxidation (Casella, Gullotti et al. 1992) and demethylation (Kedderis, Koop 
et al. 1980; Kedderis and Hollenberg 1984).  
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 The structures of the above reaction intermediates, together with how they convert to 
other intermediates in the catalytic cycles are summarized in Fig. 1.3; as indicated, halide 
ions, organic substrates, and H2O2 compete with each other for reaction with Cpd I (Sun, 
Kadima et al. 1994), thus the actual reaction depends on several factors including pH, 
substrate, and solvent (Araiso, Rutter et al. 1981). 
 
 
 
Figure 1.3 Structures of a variety of intermediates formed during CPO catalyzed 
reactions. For classic peroxidase reaction: Cpd I ⇒ Cpd II ⇒ Resting state (without 
oxygen transfer to the substrate); for halogenations reactions: Cpd I ⇒ Cpd X, Cpd X 
could release hypohalous acid (HOX) as one of the halogenating species; for epoxidation, 
and sulfoxiation reactions: Cpd I ⇒ Resting state (oxygen transfer to the substrate). 
 
1.2.2 Structure of CPO 
Although mature CPO contains 299 aa, it is initially produced as a 372-aa precursor 
which is subsequently processed by proteolytic cleavage: A 21 aa N-terminal signal 
peptide, and a 52 aa C-terminal propeptide are removed, (Fang, Kenigsberg et al. 1986). 
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The 3-dimensional structure of mature CPO was solved by crystallographic refinement in 
1995 (Sundaramoorthy, Terner et al. 1995) (Fig 1.4). Structural studies offer insights into 
the mechanism, versatility, and enantioselectivity of CPO. 
 
 
 
Figure 1.4 Chloroperoxidase crystal structure (complex with Mn2+). The figure was 
copied from Sundaramnoorthy et al (Sundaramoorthy, Terner et al. 1995). 
 
   As shown in Fig. 1.4, the scaffold of CPO consists of eight α–helices (Rubin, 
VanMiddlesworth et al. 1982; Sundaramoorthy, Terner et al. 1995). Unlike most 
peroxidases and cytochrome P450s, where the α-helix on the proximal side is near the 
C-terminal, and lies parallel to the heme; in CPO, it is near the N-terminal, and lies 
perpendicular to the heme. The exact role of this structural feature, however, is still 
unknown (Sundaramoorthy, Terner et al. 1998). The crystal structure also shows that 
CPO is extensively glycosylated with both N- and O-linked oligosaccharide chains. There 
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are three N-linked oligosaccharide chains and eleven O-linked oligosaccharide chains.  
The O-glycosylation sites are in the C-terminal domain, which contains numerous serine 
and threonine residues. (Sundaramoorthy, Terner et al. 1995). 
The catalytic center of CPO contains a single high spin protoporphyrin IX (heme) 
that is sandwiched between an N-terminal and a C-terminal helix. In CPO, the iron atom 
is penta-coordinated, with four pyrrole nitrogens of the porphyrin and a sulfur of cysteine, 
a feature that had only been observed previously in P450s (Boddupalli, Hasemann et al. 
1992; Hasemann, Kurumbail et al. 1995). For other peroxidases, it is histidine ligated to 
the heme center.  
Even though CPO’s uniquely folded tertiary structure does not resemble that of 
peroxidase or P450, CPO shares some structural similarities with both types of enzymes. 
Both P450 and CPO have cysteine as the proximal ligand, while peroxidases have 
histidine. The hydrogen-bonding networks close to the proximal cysteine are also similar. 
P450 and CPO allow organic substrates to approach the heme iron, but peroxidases only 
allow organic substrates to approach the side of the heme. The distal heme surface that 
surrounds the peroxide binding site is polar in both peroxidases and CPO, but not P450. 
An important difference between peroxidase and P450 is the accessibility of the 
heme center. In peroxidase, substrate-protein interactions are limited to the heme edge as 
access to the ferryl center is blocked. Therefore, radicals are produced from aromatic 
organic substrates as only electrons are transferred. (Hewson and Hager 1979; Schulz, 
Devaney et al. 1979). P450s, however, allow organic substrates access to the ferryl center, 
as they have an active-site pocket directly adjacent. Thus, P450s can lock the substrate in 
place and transfer oxygen atoms for stereoselective and regioselective hydroxylations. In 
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a similar fashion as P450, CPO allows organic substrates access to the ferryl center. On 
the distal side of the heme center in CPO, there is a shallow hydrophobic pocket, where 
hydrophobic substrates likely bind (Hasemann, Kurumbail et al. 1995). The channel to 
access the ferryl center is relatively polar and wide at the top but mostly hydrophobic 
near the heme (Sundaramoorthy, Terner et al. 1998). Three hydrophobic amino acids 
Phe103, Val182, and Phe186 are positioned at the bottom of the opening to the ferryl 
center (Sundaramoorthy, Terner et al. 1995) and are proposed to interact with the 
substrates, as well as to control the size of substrate that enters the active center. 
Compared to other peroxidases, such a structure can enable CPO to hold substrates in a 
specific conformation, and accounts for its highly enantioselective and regioselective 
reactions.  
Chloroperoxidase, in general, chlorinates substrate with low regioselectivity and non 
stereospecificity; however, glycols and steroids are exceptions. Therefore, there must be 
an interaction between glycols and steroids, and CPO (Libby, Thomas et al. 1982; Geigert, 
Neidleman et al. 1983). Stereospecific epoxidation and sulfoxidation of organic 
substrates also suggests binding at the active site of CPO (Casella, Gullotti et al. 1992; 
Casella, Poli et al. 1994). The binding of CPO to cis-β-methylstyrene has been modeled 
using information from the crystal structure as shown in Fig. 1.5, since CPO catalyze the 
expoxidation of substrates with an enantiomeric excess (ee %) up to 96%. Both Phe103 
and Phe186 are proposed to interact with the substrate and account for the high 
enantioselectivity  
Except for the absence of a sixth ligand, the distal region has little similarity to other 
peroxidases. On the distal side of CPO, there is a water molecule 3.4 Å away from the 
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Figure 1.5 cis-β-methylstyrene docked in the substrate pocket of CPO. The figure was 
copied from Sundaramoorthy et.al. (Sundaramoorthy, Terner et al. 1998). A 
semi-transparent molecular surface diagram with the docked cis-β-methylstyrene (in 
yellow) located just above the heme outlined (in red). 
 
heme iron (Sundaramoorthy, Terner et al. 1995; Wang, Tachikawa et al. 2003). This water 
molecule is displaced by the incoming H2O2 during reactions. Instead of a distal histidine 
or arginine found in other peroxidase, Glu183 is the residue closest to the heme iron, and 
is proposed to be responsible for breaking the peroxide bond during the formation of Cpd 
I. The required high redox potential to oxidize substrate like chloride may explain why 
CPO has an acidic pH optimum, since the acidic amino acid Glu183 needs to perform a 
similar role as the basic amino acid in other peroxidase and Cpd I usually exhibits higher  
redox potential at acidic pH value (Sundaramoorthy, Terner et al. 1998). 
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 Glutamic acid 183 is thought to act as a shuttle that transfers a proton from the 
proximal O atom of the Fe-HOOH complex to the distal O atom. Initially, deprotonated 
Glu183 removes a proton from the incoming HOOH (Kuhnel, Blankenfeldt et al. 2006). 
The resulting HOO- anion then binds at the heme producing a ferric-hydroperoxo species, 
also called compound 0 (Cpd 0) (Denisov, Dawson et al. 2007). Subsequently, the distal 
oxygen of Cpd 0 is protonated by neutral Glu183, the O–O bond is broken, and water is 
released to form Cpd I. The mechanism is similar to the Poulos-Kraut mechanism for 
peroxidases except that Glu is used instead of His. Glutamic acid 183 is proposed to be 
held in position by a hydrogen bond to His105, which may also provide charge-charge 
stabilization. Furthermore, the cleavage of H2O2 could be facilitated by Glu183, His105, 
and Asp106 acting as a proton relay shuttle (Fig. 1.6) (Pelletier, Altenbuchner et al. 1995; 
Wang, Tachikawa et al. 2003). 
Among CPO-substrate complexes, only the binding of CPD and acetate caused 
minor conformational changes at the active site. In both cases, to make room for the 
substrate, there was a 0.5 Å shift of the side chain of Phe103 away from the active site. In 
all structures determined so far, the position of the catalytically important Glu183 has 
been fixed. The side chain carboxylate group of Glu183 is “locked”, because it is 
hydrogen bonded to His105 and a water molecule that is hydrogen bonded with the 
propionate group of the heme. In addition, the carboxylate group of Glu183 is held in 
position by pi-pi interactions with the heme. Not surprisingly, the “locked” Glu183 side 
chain has similar B-factors as the nearby main-chain atoms. Asn74 was also involved in 
stabilizing several substrate by forming hydrogen bond with their carboxyl group 
(Kuhnel, Blankenfeldt et al. 2006). 
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Figure 1.6 The active center of CPO. Residues His105, Asp 106, and Glu183 on the distal 
side and residues from Arg26 to Pro30, Asn33, and Asn37 on proximal side of the heme 
are indicated. Coordination of the proximal ligand to the heme is represented by a solid 
line. Hydrogen bonds are indicated by dashed lines. 
 
Asp106 
His105
Glu183 
Pro28 
Pro30
Ala27 
Asn37
Asn33
Cys29
Arg26
 
 
15 
 
1.3 Heterologous CPO expression 
 Due to advances in biotechnology, cloned genes can be heterologously expressed in a 
controlled manner and the resulting protein purified, however, the system needs to be 
carefully selected. Site directed mutagenesis studies are usually undertaken only after the 
successful expression of the native protein, (Frandsen, Dupont et al. 1994; Inoue, Hayashi 
et al. 1996; Sriprang, Asano et al. 2006). Because the expression of native CPO involves 
glycosylation, incorporation of a heme prosthetic group, formation of disulfide bonds, 
and the cleavage of N- and C-terminal peptides, production of CPO in prokaryotes, which 
perform these activities poorly, if at all, will be challenging. Not surprisingly, the 
expression of CPO in Escherichia coli (E. coli) has had only limited success, the results 
showed that the non-glycosylated enzyme was obtained in its apoform without the heme 
being incorporated into the enzyme. Only under high pressure, can the protein be 
refolded with heme to generate a somewhat active enzyme in very low yield (Zong, 
Osmulski et al. 1995).  
 Therefore, the expression of CPO in several eukaryotic systems was investigated. 
When the CPO gene was expressed in Baculovirus only an inactive form of the protein 
was obtained (Wang, Yao et al. 2003), and the active protein could not be reconstituted.  
Expression of the CPO gene in yeast, Saccharomyces cerevisiae and Pichia pastoris also 
did not lead to the production of active protein (Zong 1997). Expression of a mutant of 
CPO in the parental host itself, C. fumago has also been reported (Yi, Mroczko et al. 
1999). However, the presence of residual wild type CPO (Wt CPO), complicated the 
selection of recombinant CPO producing strains and did not provide sufficient 
recombinant protein (rCPO) for subsequent investigations. 
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 Recombinant CPO with catalytic properties almost identical to Wt CPO was reported 
in 2001 by Conesa et al. (Conesa, van De Velde et al. 2001). The rCPO was produced in 
the filamentous fungus Aspergillus niger (A. niger). Two years later, the same group 
reported the successful expression and characterization of the E183H mutant of CPO (Yi, 
Conesa et al. 2003).  
1.3.1 Aspergillus niger expression system 
 The industrial production of heterologous proteins in filamentous fungal species is 
wide spread for three main reasons: First, filamentous fungi can secrete large quantities 
of protein into the surrounding media (Lubertozzi and Keasling 2009); Second, their use 
in the commercial production of small molecules via fermentation has led to familiarity 
(Lubertozzi and Keasling 2009); Third. the availability of a complete genetic map for 
some species, the successful development of procedures for performing molecular 
biology, and a good genetic system (Visser, Bussink et al. 1995; Gouka, Punt et al. 1996). 
One of the most common fungal species of the genus Aspergillus is A. niger. It is 
characterized by its black spore, by which it is named after (Daboussi, Djeballi et al. 
1989). Aspergillus niger is used for the commercial production of both small molecules 
and proteins. Citric acid and gluconic acid are obtained from A. niger fermentations. 
Glucoamylase, used in the production of high fructose corn syrup, comes from A. niger 
(Kriechbaum, Heilmann et al. 1989). Isotopically labeled macromolecules for NMR 
analysis can be obtained from A. niger fermentations (Roth and Dersch 2010). 
 In the past decade, A. niger and other filamentous fungi have emerged as powerful 
host systems for expressing recombinant proteins (Punt, van Biezen et al. 2002). 
Aspergillus niger is a eukaryotic host, able to perform post-translational modifications, 
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and is extraordinary in its capability of secreting large amounts of proteins, metabolites, 
and organic acids into the growth medium (Visser, Bussink et al. 1995; Withers, Swift et 
al. 1998). For decades, the food and beverage industry has used these advantageous 
properties to successfully obtain compounds from the secretion of filamentous fungi. 
Recombinant proteins of fungal origin can be produced in A. niger, at the grams per liter 
level (Spencer, Morozov-Roche et al. 1999; Conesa, van den Hondel et al. 2000). In 
addition, a full genetic map is available and annotation is nearly complete (Swart, Debets 
et al. 2001). 
 Methods for the genetic manipulation of Saccharomyces and E. coli were greatly 
simplified by the discovery of plasmids, natural extrachromosomally replicating DNA 
elements. Unfortunately, Aspergillus lacks such elements, as is the case for most fungi. 
Transformations in Aspergillus occur via genomic integration of the transforming DNA.  
The transforming DNA can be incorporated at homologous and non-homologous (ectopic) 
sites, and even multiple times. The situation is half way between that of yeast and 
mammalian cells. In yeast, transforming DNA is usually incorporated at the homologous 
site with low frequency while in mammalian cells, transforming DNA is incorporated at 
non-homologous sites with high frequency and any homologous recombination is 
difficult to detect (Fig. 1.7) (Chakraborty, Patterson et al. 1991). Although 50 or more 
copies of the transforming DNA can be incorporated into Aspergillus, single digits 
frequencies are more common (Turnbull, Smith et al. 1990). Aspergillus cells containing 
multiple copies are, in general, mitotically stable (Liu, Liu et al. 2003). For several 
reasons, it would, however, be desirable to have a single event at the homologous site 
(Verdoes, van Diepeningen et al. 1994). Firstly, the number of copies in the genome does 
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Figure 1.7 The chromosomal integration of vector DNA into Aspergillus. The figure was 
copied from (Lubertozzi and Keasling 2009). (A) Integration of circular plasmid by 
single crossover. Plasmid (shaded) bearing wild type marker (gray) recombines with 
auxotrophic mutant host chromosome (gray with black bar indicating mutation). (I) Type 
I or homologous integration. (II) Type II or ectopic integration; the dark gray bars 
represent an interrupted gene sequence. (III) Type III gene replacement; here the 
chromosomal marker is replaced by the plasmid copy, restoring it to wild-type. (B) 
Integration of a plasmid bearing a truncated wild-type marker; only recombination at the 
homologous locus reconstitutes the functional marker gene. Sequence A′ to M′ on the 
plasmid is homologous to A to M in the target; the black bar indicates location of 
amutation in auxotrophic host. (C) Insertion of linear DNA; here A′ to M′ and N′ to 
Z′flanking the marker (darker gray) are homologous sequences corresponding to those at 
A to M and N to Z, respectively, in the chromosomal target (lighter gray). 
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not correspond with protein expression levels. Secondly, the location of the DNA within 
the genome can alter its expression level significantly. When the position of native genes 
within the genome are changed, their expression levels vary dramatically (Conesa, van 
den Hondel et al. 2000). Thirdly, incorporation of DNA randomly into the genome will 
cause mutations and, correspondingly, unpredictable side effects (Ruiz-Diez 2002). Cells 
with at least one homologous integration event can be selected for by using a truncated or 
mutated form of a wild-type selection marker (Hanegraaf, Punt et al. 1991). Although 
several systems have been developed based on the method outlined above, and 
Aspergillus is used to produce small molecules and proteins commercially, the expression 
of proteins in Aspergillus is still not straight forward and remains quite challenging 
(Mooibroek, Kuipers et al. 1990; Turnbull, Smith et al. 1990; Verdoes, Punt et al. 1993). 
Since versatile DNA transfer and gene expression systems are developed for these 
organisms, the necessary tools are available for the production of recombinant proteins 
(Juge, Svensson et al. 1998). Furthermore, A. niger has no detectable extracellular and 
intracellular peroxidase, and therefore, in contrast to the C. fumago system, no 
interference of endogenous oxidizing activities when screening for CPO producing 
transformants (Conesa, van den Hondel et al. 2000). In the past ten years, several reports 
on the expression of metalloproteins in filamentous fungi have been published (Juge, 
Svensson et al. 1998; Conesa, Jeenes et al. 2002). However, although production of 
active recombinant enzymes was found in most cases, yield levels were still far away 
from those obtained for less complex fungal proteins, making the secretion of 
metalloproteins an intriguing subject of study (Gordon, Khalaj et al. 2000; Ngiam, Jeenes 
et al. 2000).  
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 The host of choice for CPO expression, A. niger MGG029, is frequently used for the 
heterologous expression of proteins because it has many favorable attributes. The strain is 
protease deficient as result of a regulatory mutation, which reduces the number of 
endogenously expressed proteases. In addition, the strain is missing the glaA gene, which 
is responsible for the production of glucoamylase (GLA). Therefore, the secretion of 
GLA can be used to indicate the successful expression of a GLA fusion construct. 
Furthermore, A. niger MGG029 carries a nonfunctional pyrG, thus, pyrG can be used as a 
selection marker (Conesa, van De Velde et al. 2001). 
 The transforming vector pCPO3.I contains the full length CPO coding sequence 
placed under control of the A. niger glucoamylase promoter and A. nidulans trpC 
terminator. Aspergillus nidulans AmdS selection marker was introduced in pCPO3.I at a 
unique NotI site to obtain the CPO expression vector pCPO3.I-AmdS (Fig. 1.8) (Conesa, 
van De Velde et al. 2001). The vector also contains the pU19 vector sequence to enable 
its multiplication in E. coli and so that it can be shuttled between E. coli and A. niger.  
1.3.2 Factors that affect CPO expression in Aspergillus niger 
 As described earlier, one advantage of the A. niger expression system is its ability to 
secret peroxidase into the extracellular medium in high quantity (Conesa, Punt et al. 
2002). This property of extracellular secretion is very important for the expression of 
sufficient recombinant protein for structure and mechanism studies in the laboratory, 
since CPO is more stable in the acidified culture media, and can also help to simplify the 
purification procedures. In order to improve the in general low production yields, the 
process of overproduction of heme-containing proteins, has been subjected to numerous 
studies in the past, (Gouka, Punt et al. 1997; Conesa, van den Hondel et al. 2000).  
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Figure 1.8 The expression vector for co-transformation of A. niger. The figure was copied 
from Conesa et.al (Conesa, van De Velde et al. 2001) 
 
For heme-containing proteins, limited heme availability has been indicated as a limiting 
factor. The production of rCPO could be increased by heme addition to the culture 
medium (Conesa, van De Velde et al. 2001). Similar results have been obtained in 
previous studies by our group and other groups on the expression of fungal peroxidase in 
Aspergillus species (Yi, Conesa et al. 2003). However, experiments show that despite 
heme supplementation, rCPO was only partially (40%) incorporated with heme (Yi, 
Conesa et al. 2003). It is in contrast to observations on the production of Phanerochaete 
chrysosporium manganese peroxidase in A. niger, where the recombinant enzyme could 
be produced with the same heme content as the native protein (Conesa, Punt et al. 2002). 
A possible reason for this different behavior may be the different nature of heme 
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attachment in the manganese peroxidase (axial ligand: histidine) and CPO (axial ligand: 
cysteine).  
 The addition of δ-aminolevulinic acid (ALA) as heme precursor to the culture 
medium increased the secretion level of the E183H mutant of CPO by 4-fold (Yi, Conesa 
et al. 2003). δ-aminolevulinic acid synthase is thought to be a crucial enzyme in the 
regulation of heme synthesis. There are a few reports regarding an increase in heme 
protein production by ALA inducement. Another alternate way to overcome heme 
limitation is addition of hemoglobin to culture media. During the production of 
manganese peroxidase (MnP), heme supplementation in the form of hemoglobin or 
hemin was shown to significantly increase protein production as measured by 
extracellular MnP activity, although, the specific activity of MnP did not increase. 
Therefore, the apoform of rMnP is probably being degraded inside or outside of the cell, 
while only the haloform is stable enough to be secreted and preserved in the extracellular 
medium. Interestingly, iron supplementation alone did not increase the production of MnP, 
suggesting that the increased activity was not a consequence of the additional iron within 
the hemoglobin or hemin. Higher production yields were achieved with hemoglobin 
supplementation rather than hemin supplementation, indicating that adding heme to the 
culture media was important but that adding protein to the culture media might also be 
favorable. The addition of bovine serum albumin (BSA) or apohemoglobin had a positive 
effect on production levels, strongly suggesting that addition protein in the media protects 
rMnP from degradation caused by proteases or other pathways (Conesa, van den Hondel 
et al. 2000). 
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Figure 1.9 The secretion pathway in filamentous fungi. The figure was copied from 
Conesa et.al. (Conesa, Punt et al. 2001). Cloned secretion related GTPases (srg A–F), 
involved in vesicular trafficking, are indicated: N, nucleus; V, vacuole; ER, endoplasmic 
reticulum; G, Golgi apparatus; SV, secretion vesicles. 
 
Overproduction of heme-peroxidases places a heavy load on the protein secretory 
machine. Overall, the protein secretory machine in filamentous fungi does not differ 
greatly from those in yeast and higher eukaryotes, for which a more complete picture is 
available. However, there must be important differences in the details. The level of 
protein secretions in filamentous fungi can reach 30 g/L (Aspergillus and Trichoderma 
strains) (Punt, Veldhuisen et al. 1994), while in yeast a level of more than a gram per liter 
is found for only a few species, such as Pichia (Visser, Bussink et al. 1995). 
The fungal secretory pathway is illustrated in Fig. 1.9. For secretory proteins, the 
first step is to enter the endoplasmic reticulum (ER). In the ER, the proteins are folded 
and undergo some distinct posttranslational modifications, including disulfide bridge 
formation, glycosylation, phosphorylation, and subunit assembly (Conesa, Punt et al. 
2001). The proteins then leave the ER inside vesicles, which are directed to the Golgi 
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apparatus. In the Golgi apparatus, additional posttranslational modifications may take 
place including additional glycosylation and peptide processing. The proteins then leave 
the Golgi apparatus packed inside secretory vesicles. In most cases, the secretory vesicles 
are then sent to the plasma membrane and the proteins inside are secreted into the 
extracellular media. In some cases, instead of being directed to the plasma membrane, the 
vesicles and the proteins inside are sent to other intracellular compartments, such as 
vacuoles. Inside the vacuole, the protein will most likely be degraded via proteolysis 
catalyzed by proteases. Protein secretion is proposed to occur from the apical or subapical 
hyphal portions of the fungus (Conesa, Punt et al. 2001).  
 One key factor that regulates the production of recombinant proteins is presence of 
molecular chaperones. Molecular chaperones promote protein folding by binding 
transiently and noncovalently to protein folding intermediates. Once bound to the 
chaperone the folding intermediates are less likely to have unfavorable protein-protein 
interactions that might lead to protein aggregation or misfolding. Therefore, molecular 
chaperones are not regarded as “true’ catalysts but as proteins that assist folding. 
Chaperones and foldases are conserved between organisms and are present throughout 
the cell including in the cytosol, chloroplasts, the ER, and mitochondria (Gouka, Punt et 
al. 1996). For CPO, the CPO C-terminal pro-peptide may behave as a molecular 
chaperone, so that it can assist CPO to fold into its correct conformation, because the 
CPO sequence corresponding to the mature protein produced no active CPO when cloned 
into A. niger. The mechanism of this function, however, is still unknown (Conesa, 
Weelink et al. 2001). 
 
 
 
25 
 
1.4 Objectives of this work 
 For my dissertation, I first attempted to optimize the growth and expression condition 
for the A. niger strain to increase the purity and yield of recombinant proteins, so that I 
could rely on such a system for future studies. Also verification and a structural study 
using NMR spectroscopy were done on rCPO. Next, I produced site-directed mutants of 
CPO using A. niger as the host. By studying the function and mechanism of the mutants, 
I further elucidated the stucture of CPO’s active site and its role in regulating CPO’s 
catalytic activities and enantioselectivity. A very interesting and promising CPO mutant 
F103A was successfully produced and studied as part of my research. In addition, 
possible industrial applications of CPO were explored and examined. An attempt to 
obtain a CPO triple mutant C29H/C79H/C87H was made; however, it failed to produce 
active form of protein, probably a result of the instability of the triple mutant.  
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Chapter II 
Optimization of Aspergillus niger expression system and NMR study of recombinant 
CPO 
2.1 Material and methods 
2.1.1 Strains and reagents 
Recombinant CPO (rCPO) expressing A. niger strain pCPO3.1#5, which had been 
co-transformed with CPO expression vector pCPO3.1-amds and assistant plasmid 
pAB4.1, was kindly provided by Dr. Punt (TNO Nutrition and Food Research Institute, 
The Netherlands). Rabbit anti-CPO polyclonal IgG was also provided by Dr. Punt. Unless 
otherwise noted, all other chemicals and reagents were obtained from commercial sources 
and used without further purification.  
2.1.2 Genomic DNA extraction and sequencing 
 Spores of A. niger were inoculated and cultured for 2 d in minimal medium. The 
mycelia sample were collected by centrifuge and re-suspended in an isosmotic buffer (1 
g/20 mL). The cell wall was then partially digested by incubating with a lysing enzyme 
from Trichoferma harziannum (10 mg/20 mL, Sigma L-1412) for 4 h. The mycelia were 
again collected by centrifuge. The DNA extraction was performed with a QIAGEN plant 
DNA mini kit (QIAGEN, CA). The extracted DNA was then used as a template and 
amplified with primers (5'-cgc gga tcc atg ttc tcc aag gtc c -3' & 5'- ccg gaa ttc aag gtt gcg 
ggc-3’) that flanked the CPO coding region. Co-transformants containing the expression 
cassettes were confirmed by the presence of a band at 1122 bp. The extension temperature 
for the PCR reaction was optimized to 56.3 ºC. 
 
 
27 
 
2.1.3 Expression of rCPO  
 Fungal culturing was carried out in 2-L Erlenmeyer flasks containing 1 L of A. niger 
minimal growth medium with 5% maltose and supplemented with 0.5% casein amino 
acids. Cultures were inoculated with a whole Petri dish of conidia. After incubation in a 
rotary shaker revolving at 225 rpm for 24 h at 25 ºC, the temperature was lowered to 22 
ºC and the shaking was continued for 6 d. Hemin (500 mg/L) was added either at the time 
of or 48 h after inoculation. Crude medium was checked for chlorination activity (MCD 
assay), using the MCD assay to monitor for the production of rCPO, on a daily base. 
2.1.4 Purification of rCPO  
 Aspergillus niger crude medium samples were collected by filtering the fungal 
culture through Miracloth and then centrifuging at 9500 rpm for 1 h, followed by 
filtration though 0.8 µm filters to further remove mycelia debris. The crude culture 
medium containing the secreted enzyme was concentrated about 200 to 400 fold using a 
high output ultrafiltration cell (10 kDa cut off membrane, Millipore). The condensed 
medium sample (20 mL) was dialyzed twice against 25 mM potassium phosphate buffer 
(4 L) at pH 5.9 for at least 24 h to adjust the pH value and to obtain the proper 
conductivity. The sample was then applied to a DEAE Sepharose fast flow (Amersham) 
column (2.6 × 20 cm). After an initial wash to remove the unbounded protein, the mutant 
enzyme was eluted from the column by using a stepwise ionic strength gradient of 25 mM 
potassium phosphate buffer at pH 5.9 containing 0-0.5 M sodium chloride. The flow rate 
was adjusted to 1 mL/min. The Reinheitzahl value (Abs400 nm/Abs280 nm) was used to 
check the purity of each fraction. Fractions having an Rz value greater than 0.9 were 
collected, then concentrated using a Centriprep-YM30 concentrator (Amicon). Further 
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purification was done by gel filtration on a Sephadex G-75 (Amersham) column (2.6 
× 100 cm) with 50 mM potassium phosphate buffer (pH 4.6, 0.5 mL/min). All 
purification steps were done either on ice or in a cold box at 4 ºC.  
2.1.5 Western blotting procedure 
 The SDS-PAGE gel was placed next to a nitrocellulose membrane. At room 
temperature, the protein samples were transferred from the SDS-PAGE gel to the 
nitrocellulose membrane using 50 V, and 164 mA for 1 h. The membrane was then 
incubated with blocking buffer (5% non-fat milk in Tris buffered saline with tween 
(TBST) for 1 h at room temperature with agitation. The membrane was washed 3 times 
for 5 minutes each with TBST and incubated with rabbit anti-CPO polyclonal IgG 
antibody in the same buffer with 5% BSA for 16 h at 4 ºC with agitation. After 
incubation, the membrane was washed and then incubated with horseradish 
peroxidase-conjugated anti-rabbit IgG antibody for 1 h. After this secondary antibody 
incubation step, the membrane was washed and 3 mL of SuperSignal (1.5 mL 
Luminol/Enhancer, 1.5 mL 2x Hydrogen Peroxide) was added. After 1 min of gentle 
agitation, images were recorded by using X- ray film with an exposure time of 5 to 60 s. 
2.1.6 Circular Dichroism spectrum study 
 Far-UV-CD (Circular Dichroism) spectra were recorded on a JASCO J-720 
spectropolarimeter at room temperature. Spectrum was recorded from 190 to 250 nm at 
0.1-nm intervals with a spectral bandwidth of 1 nm. The path length was 1 cm. 
2.1.7 UV-visible absorption spectrum study  
 All UV-visible (UV-vis) absorption measurements were determined in a VARIAN 
Cary 300 spectrophotometer using a 1-cm path length quartz cuvette.  
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2.1.8 Enzyme activity assays  
Chlorination Assay (MCD assay) — the chlorination rate of monochlorodimedone 
(MCD) was used to measure the chlorination activity of CPO (Yi, Conesa et al. 2003). 
The 3 mL reaction mixture contained 100 mM potassium phosphate buffer at pH 2.75, 20 
mM KCl, 0.17 mM monochlorodimedone, 2 mM H2O2, and a suitable aliquot of CPO. 
The reaction was initiated by the addition of H2O2, and the decrease in absorbance at 278 
nm was monitored at room temperature. One unit of chlorination activity was defined as 
the conversion of 1 µmole of MCD per minute.  
2.1.9 NMR spectroscopy 
 The NMR samples of rCPO (~1.5 mM) were prepared in 100 mM potassium 
phosphate buffer at pD/pH 5.5 in either D2O buffer or 90% H2O/10% D2O buffer. In D2O 
the pH meter reading was adjusted by 0.4 units to account for solvent isotope effects. In 
90% H2O/10% D2O buffer no adjustment was made. Preparation of rCPO in D2O 
involved four buffer exchanges with D2O buffer at pD 5.5 starting from solutions of 
rCPO in H2O. The exchanges were accomplished at 4°C using a Centricon or Centriprep 
from Amicon. The protein concentration was determined from its absorbance at 398 nm 
(ε = 91.2 x 103 M-1cm-1). The rCPO-CN adduct was prepared by addition of a 1.1-1.2 
molar equivalents of KCN in D2O, from a freshly made KCN stock solution (0.5 M). 
 Proton NMR spectra were recorded on a Bruker Avance 600 (Ultrashield) NMR 
spectrometer operating at a proton frequency of 599.97 MHz. The residual solvent signal 
was suppressed with pre-saturation during relaxation delay. Chemical shift values were 
referenced to the residual HDO signal at 4.76 ppm. All NMR spectra were acquired at 
298 K unless otherwise noted. For variable temperature experiments the chemical shift of 
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the residual HDO signal was assigned a value according the relationship of δT = δ25 − 
0.012 (T − 25), where δT is the chemical shift of HDO at temperature T in °C, and δ25 is 
the chemical shift of HDO at 25 °C (Satterlee, Erman et al. 1983); The value of 4.76 ppm 
instead of the usual 4.81 ppm was selected to be consistent with previous experimental 
work on CPO (Wang, Tachikawa et al. 2003). 
 All two-dimensional data were processed on an HP Workstation with a Pentium 4 
processor using Topspin 1.3 (Bruker). Various apodization functions were employed to 
emphasize protons with different relaxation properties. The spin-lattice relaxation times 
(T1) were determined from 16 spectra obtained at 25 °C with delay times ranging from 
0.1 to 500 ms. After processing with Topspin each spectrum was downloaded into 
Microsoft Excel to determine peak heights and the resulting data curve fit using Sigma 
Plot. 
2.2 Results and discussion 
2.2.1 Optimization of rCPO production and purification procedure for rCPO 
 One obstacle presented in a previous report using the A. niger expression system was 
the very low production of the purified enzyme, at most 10 mg/L compared to 300 mg/L 
for Wt CPO produced by C. fumago; in addition, the heme incorporation rate of the 
enzyme was very low. While pure CPO has an Rz value higher than 1.44, the purified 
rCPO only had an Rz value of 0.54. These two shortcomings plus a low-yield purification 
procedure made it impractical to obtain sufficient protein for detailed structure and 
mechanistic studies. Thus, improved production yields, heme incorporation rates, and 
purification procedures were essential for the success of the project. 
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 First, heme and heme precursor were added, as previous studies on the expression of 
other fungal peroxidase in A. niger had demonstrated that incomplete incorporation with 
prosthetic group was a major issue (Conesa, van De Velde et al. 2001). For example, 
Conesa has reported that rCPO produced by MGG029 was only partially (40%) 
incorporated with heme even after heme supplementation (Conesa, van De Velde et al. 
2001). Table 2.1 shows the comparison between rCPO yield, and culture media with and 
without heme supplementation. When 500 mg of hemin was added at inoculation, protein 
production levels were similar to those reported previously. However, when hemin was 
added 48 h after inoculation, protein production was increased by 5-10 fold. Interestingly, 
the highest protein production (30.42 mg/L) was achieved without hemin addition at all, 
and protein production levels could be increased by 4-29 fold. Therefore, it seems that 
addition of heme to medium may have a toxic effect on the growth of A. niger. 
 
Table 2.1 Optimized condition for production of rCPO after 72 h culture 
Culture of Aspergillus niger  
 
rCPO activity 
(unit/mL) 
Estimated rCPO 
production yield  (mg/L) 
Reported in reference 
 
1.60   1.14  
Hemin (500 mg/L) added at  
inoculation  
1.63  1.16  
Hemin (500 mg/L) added 
 after culture reach plateau (48 h)  
8.52~19.7   6.08~14.07  
No heme addition 
  
6.28~42.6   4.49~30.42  
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 Two additional factors were examined to improve rCPO production yield: pH 
stability and culture time. Aspergillus niger strains are known to produce large amount of 
organic acids that acidify the culture media. Overly acidic crude media will denature the 
secreted protein before it is folded and processed to the functional protein. Readjusting 
the pH with greater than 1 M KOH, might further denature the protein locally as well, 
and lower concentrations of KOH are impractically as they significantly dilute the media 
due to the high concentration of organic acids. Thus, over acidification might have a 
profound effect on expression level. In order to minimize acidification, different carbon 
sources were added into the culture media. The mycelia of a hyper productive CPO3.1#5 
strain were used to inoculate one batch of 3x1 L cultures containing 5% maltose and no 
glucose, and another batch of 3x1 L cultures with maltose (5%) and glucose (1%). The 
pH values of the crude media were checked daily and the pH value was readjusted to 5 
using 1 M KOH if necessary. After 7 days, flasks without glucose, had rCPO production 
yields of 7, 13, and 15 mg/L, and the flasks with glucose, had rCPO production yields of 
36, 46, and 48 mg/L as determined by the MCD assay. In addition, the flasks without 
glucose reached to pH 3 after only two days, while the flasks with glucose never reached 
pH 3 during the course of the experiment. The pH values stayed between 4 and 5 for over 
7 days, and there was no need to adjust the pH. 
 In previous work using A. niger as a heterologous expression host to express 
heme-containing proxidase, all culture media were collected either 48 h or 72 h after 
inoculation, probably because of factors such as the intrinsic stability of the enzyme and 
the denaturation effect of over acidification. Since CPO is very stable under acidic 
conditions, prolonged culture times could benefit the production of rCPO. The results of 
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rCPO production yields versus culture time are showed in figure 2.1. The rCPO 
production yields after 3, 4, 5, 6, and 7 days of inoculation, were 16, 29, 40, 48, and 56 
mg/L, respectively. Further improvements in production efficiency were achieved by 
controlling the temperature. The initial culture temperature was increased from 22 ºC to 
25 ºC to help A. niger reach its maximum biomass faster, then the temperature was 
lowered to facilitate the secretion of rCPO. In addition, lower temperatures would help to 
stabilize the secreted enzyme. By increasing the incubation time and adjusting the 
temperature, the rCPO production yield was further increased to 85 mg/ L. 
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Figure 2.1 rCPO production yields versus days after inoculation.  
 
A few modifications were also made to the rCPO purification procedure. A stepwise 
rather than a linear ion strength gradient was used in the ion-exchange chromatography 
step. In the gel filtration chromatography step, a smaller sample volume (<0.5% column 
volume) and slower flow rate (0.5 mL/min instead of 1 mL/min) were found to improve 
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the resolution. The chromatography results of rCPO purification are shown in Fig. 2.2 & 
Fig. 2.3. Compared to the published rCPO purification table (Conesa, van De Velde et al. 
2001), the results (Table 2.2) demonstrated an approximately 2.5 times higher recovery 
rate and 2.6 times higher purity, thus enabling us to carry out an NMR study. Ultimately, I 
increased the overall production of pure rCPO to 85 mg/L and the Rz value of purified 
rCPO was up to 1.4. Wt CPO with an Rz value greater than 1.44 is considered pure. The 
ability to produce rCPO in high yield and purity opens the door to a greater 
understanding of the mechanism of CPO and the commercial application of mutants of 
CPO via protein engineering. 
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Figure 2.2 Chromatogram of ion exchange chromatography of rCPO. 
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Figure 2.3 Chromatogram of gel filtration chromatography of rCPO 
 
Table 2.2 Purification result of rCPO from A. niger culture 
  
Volume 
mL 
Activity 
units/mL 
Enzyme 
units 
Yield 
% 
Rz 
A400/A280 
Crude media 580  29 16820 100 ND 
Ultrafiltration  45 309 13888 82 ND 
DEAE-Sepharose  90 109  9797 58 ~1 
Sephedex G-75 40 112  4480 26 1.4 
 
2.2.2 Validation of rCPO  
Validation of rCPO was done by SDS-PAGE (Fig. 2.4) and western blotting (Fig. 
2.5). The results verified that the molecular weight of purified rCPO is slightly larger 
than that of Wt CPO. The western blot results showed the positive reaction of rCPO with  
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Figure 2.4 12% SDS-PAGE result of rCPO. Lane 1 is protein molecular weight markers. 
Lanes 2 to 4 are rCPO samples from crude media, and ion exchange and gel filtration 
purification steps, respectively. Lane 5 is a sample of Wt CPO and lane 6 is a mixed 
sample of Wt CPO and purified rCPO. According to the gel results, the molecular weight 
of the rCPO is 50 kDa and is sightly bigger than that of Wt CPO. 
 
 
 
 
Figure 2.5 Western blotting results of Wt CPO and rCPO. Proteins were detected with an 
anti-CPO polyclonal antiserum. The antibody was diluted to 1:10000 for Wt and 
recombinant CPO. 
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polyclonal antibodies, despite the different glycosylation profiles of A. niger and C. 
fumago. 
2.2.3 UV-vis & CD spectroscopic study of rCPO 
 After rCPO was verified, the UV-vis spectra of rCPO and Wt CPO (Fig. 2.6) were 
compared. The spectrum of rCPO was almost identical to that of Wt CPO in all regions 
except that the Soret band of Wt CPO was at 398 nm, but that of rCPO was at 400 nm. 
The activity assay also confirmed the validity of the rCPO (data not shown). The CD 
spectra (Fig. 2.7) also showed an essentially identical pattern between rCPO and Wt CPO 
indicating the presence of a similar secondary structure for the two proteins. 
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Figure 2.6 UV-vis spectra of rCPO and Wt CPO ( in 0.05 M potassium phosphate buffer, 
pH 5.0, at room temperature). 
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Figure 2.7 The CD spectra of rCPO (0.4 µM in 10 mM phosphate buffer, pH=6) and Wt 
CPO (0.35 µM in 10 mM phosphate buffer, pH=6). The experiments were carried out at 
room temperature and recorded from 190 to 250 nm. The path length was 1 cm. 
 
2.2.4 NMR spectroscopic study of rCPO 
 The proton NMR spectrum of the rCPO-CN adduct displayed only one set of signals, 
indicating the presence of only one isozyme (Fig. 2.8). In contrast, the proton NMR 
spectrum of the Wt CPO-CN adduct has pairwise signals because of the presence of two 
isozymes (Wang, Tachikawa et al. 2003), which complicates spectral interpretation. The 
rCPO-CN adduct was in the ferric low spin state and provided relatively sharp NMR 
signals (Fig. 2.8). Although, the adduct is not physiologically active, it is the most 
favored system for paramagnetic NMR investigation as it provides the most information 
about the magnetic, electronic and structural properties of the active site and is also a 
good mimic of reaction intermediates Cpd I and Cpd II (Satterlee, Erman et al. 1983; 
Thanabal, Deropp et al. 1987; Satterlee, Erman et al. 1990; Banci, Bertini et al. 1992).  
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 The structure of the active site of rCPO was investigated using spin-lattice relaxation 
times and Curie plots, as well as a NOESY spectrum (Table 2.3 and Scheme 1).  
 
 
 
Scheme 1 Iron protoporphyrin IX in CPO 
 
Comparisons were made with the comprehensive NMR results previously reported for 
Wt CPO (Wang, Tachikawa et al. 2003). The spin-lattice relaxation time of each 
paramagnetically shifted resonance in rCPO-CN was determined by measuring peak 
intensities as a function of relaxation times (Fig. 2.9) and then the results were curve fit to 
peak intensity = I0-2*a*e-t/T1, where I0 and a are variables corresponding approximately to 
the maximum peak intensity, t is time, and T1 is the spin-lattice relaxation constant (Fig. 
2.10). The spin-lattice relaxation times provide information about the distance between 
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the proton and the iron center (Table 2.4). The Curie plots involved plotting the chemical 
shift of a proton as a function of 1/T, where T is the temperature in Kelvin (Fig. 2.11). 
The intercept of the plot estimates the chemical shift of the proton in the absence of 
paramagnetic effects from the iron. Resonances were assigned based on analogy with the 
well-studied Wt CPO spectrum and the heme resonance was partially assigned based on 
off diagonal peaks in the COSY spectrum (Fig 2. 12) (Wang, Tachikawa et al. 2003). 
 The NOESY (Fig. 2.13) spectrum of rCPO possesses many of the same off diagonal 
peaks as that of Wt CPO. On the basis of the analogy with the Wt CPO spectrum, twenty 
four of the 37 crosspeaks observed in Wt CPO for isozyme B were identified in rCPO 
and the missing crosspeaks tended to be of lower intensity in the Wt CPO NOESY 
spectrum or may correspond to isozyme A. Off diagonal peaks between the heme 
hydrogens of rCPO and Pro28, Ala31, Phe57, Ile63, Val67, Ile68, Leu97, and Phe186 
were observed. Unlike Wt CPO, no off diagonal peak was observed between the heme 
protons and Phe57, although this is a very weak signal in the Wt CPO NOESY spectrum 
(Wang, Tachikawa et al. 2003). 
 In summary, on the basis of the NMR data, rCPO and Wt CPO have very similar 
active site structures. The 1D and 2D spectra are nearly identical, as are the T1 values and 
the intercepts of the Curie plots. The chemical shifts of the paramagnetically shifted 
resonances in isozyme B of Wt CPO and the corresponding resonances in rCPO are at 
most 0.4 ppm apart with the exception of the resonance at approximately 39 ppm, which 
is broad and has a poorly defined peak, Table 2.3. For comparison, when yeast 
cytochrome c, a non-glycosylated heme protein was expressed in E. coli, the chemical 
shifts of the paramagnetically shifted resonance of wild type and recombinant proteins  
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Figure 2.8 NMR spectrum of rCPO at 25 °C in 0.1 M potassium phosphate buffer
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Figure 2.9 Selected signals from the NMR spectra of rCPO at various relaxation times at 25 °C and pD 5.5. 
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Figure 2.11 Curie plots for selected signals of rCPO. 
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Figure 2.12 rCPO COSY plot. 
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Figure 2.13 rCPO NOESY plot and crosspeak assignments based on analogy with Wt CPO (Wang, Tachikawa et al. 2003). The 
same numbering system was used as in Wt CPO, which has additional peaks, in part, due to the presence of two isozymes. 
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Table 2.3 Spin lattice relaxation times (T1) of paramagnetic shifted resonances for rCPO 
and Wt CPO in 0.1 M phosphate buffer, pD 5.5 and 25 °C. 
rCPO Wt CPOa 
Chemical 
shift (ppm) 
T1 (ms) Intercept 
(ppm) 
Chemical 
shift (ppm) 
T1 (ms) Intercept 
(ppm) 
Assignment 
39.6  -8.5 39.0/38.3  -10.6/-9.6 Hβ-Cys29 
24.1 43 1.8 24.0/23.8 33/35 0.1/0.4 8-CH3 
20.8 38 0.4 20.7/20.4 30/34 -0.7/-0.6 3-CH3 
17.0 5 5.3 17.4/17.0 6/6 3.1/3.0 NAc
   16.3 (H2O)b 200  His105 
14.8 30 8.7 14.8 29 8.7 4- Hα 
12.9 33 4.0 14.1/12.9 35/35 3.3/2.4 7- Hα 
12.2  265 11.7 12.3/11.9 220/NRd NR/NRd CH2-Pro28 
11.9 10 3.8 12.2/11.8 NR/NRd NR/NRd CH-Phe186 
   11.6 (A)a 30 (A)a 3.5 (A)a 7- Hα’ (A)a
-1.2 52 4.4     
-1.4 54 5.4 -1.4 NRd 5.8 2- Hβtrans 
-2.5 81 3.4 -2.5 NRd 3.4 β-CH-Ile68 
-2.6 65 9.9 -2.7 70 9.7 4-Hβtrans 
-3.8 7 7.7 -3.8 7 5.5 NAc
-4.5 72 10.3 -4.4 80 10.8 4-Hβcis 
-5.1 62 4.2 -5.2 58 4.6 2-Hβcis 
-21.0 1.4 0.8 -20.7 1.5 6.4 Hβ’-Cys29 
aPairwise signals were observed for Wt CPO, the first number corresponds to isozyme A 
and the second number corresponds to isozyme B. One number corresponds to both 
isozymes unless indicated otherwise (Wang, Tachikawa et al. 2003).  . 
bSignal observed in H2O but not D2O. 
cNot assigned in Wt CPO due to several possibilities or undetermined 
dNot reported 
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Table 2.4 Distance between the selected protons and the heme iron in rCPO based upon 
spin-lattice relaxation values and from the X-ray structure of Wt CPO (Sundaramoorthy, 
Terner et al. 1995).  
Chemical Shift  
(ppm) 
T1 (ms) Assignment Predicted Distance  
(Å) 
X-ray (Å) of  
Wt CPO 
24.1 43 8-CH3 6.1 6.1 
20.8 38 3-CH3 5.9 6.0 
17.0 5 Meso-H 4.2 4.6 
14.8 30 4-Hα 5.7 5.5 
12.9 33 7-Hα 5.8 6.3 
12.2   265 CH2, Pro28 8.2 7.9 
11.9 10 CH, Phe186 4.7 3.9 
-2.6 65 4- Hβtrans 6.5 6.8 
-4.5 72 4-Hβcis 6.6 6.8 
 
aThe predicted distances were determined from the T1 values assuming that the average 
distance between the three protons of 8-CH3 and the heme iron was 6.05 Å and that T1 
varies with 1/r6. 
 
differed by up to 0.6 ppm (Satterlee, Erman et al. 1990). The chemical shifts of the 
paramagnetically shifted resonance of the two isozymes of Wt CPO listed in Table 2.3 
also differed by slightly more than 1 ppm (Wang, Tachikawa et al. 2003). Based on the 
chemical shifts of the 7-Hα protons, rCPO is slightly closer in structure to isozyme B of 
Wt CPO than to isozyme A. 
2.3. Conclusion 
Expression level is an important feature for a recombinant protein system. Structural 
and mechanistic studies requires large quantities of protein and under laboratory 
condition, it is impractical to increase the fermentation volume to compensate for low 
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production yields. It is also a very important factor for economic reasons, if future 
industrial applications of the protein are under consideration. Needless to say, high purity 
is also critical for structural and other in-depth studies of protein function. My 
optimization of the expression and purification procedure of CPO not only allows the 
production of protein with adequate purity for structural studies, but also increases the 
production efficiency of active enzyme by 7 fold. Although, addition of either 
heme-precursor or heme was proposed to increase the production yield and heme 
incorporation rate, the current work proved it to be unnecessary. My work showed that an 
Rz value of up to 1.40 can be achieved for rCPO without the use of either heme or heme 
precursor during protein expression, demonstrating at least 97% heme incorporation rate. 
The rCPO produced by A. niger was both structurally and functionally very similar to Wt 
CPO, although the glycosylation degree was different. The UV-vis, CD, and 1D and 2D 
NMR spectra were almost identical between rCPO and WtCPO. The CD data suggested 
only minor changes in the secondary structure and the NMR data suggested that the 
structure of the active site was essentially the same. Importantly, rCPO also possessed 
efficient catalytic activity as Wt CPO does.  
My work proved that A. niger is an efficient and effective system for heterologous 
expression of CPO. In addition, the results suggested that A. niger may be used to express 
heme-containing proteins from other source which have proven difficult to express 
otherwise (Zong 1997; Aburto, Correa-Basurto et al. 2008; Lubertozzi and Keasling 
2009). The results also laid a solid foundation for future studies on CPO using 
site-directed mutagenesis as demonstrated in Chapter 3 of this dissertation.  
  
 
 
50 
 
Chapter III  
F103A CPO mutant preparation and properties 
3.1 Material and methods 
3.1.1 Strains and reagents 
Escherichia coli strains DH5α and Novablue were used for the construction and 
propagation of vectors. E. coli strain XL Gold-10 was purchased from the quik-change II 
XL kit (Strategene, CA) to propagate the nicked and mutagenesis induced CPO 
expression vector. The A. niger strain MGG029 (prtT, gla::fleor, pyrG) was obtained 
from TNO Nutrition and Food Research Institute, The Netherlands and was employed as 
recipient strain in the transformation experiments. High fidelity DNA polymerase pfu 
ultra and Phusion were obtained from Stratagene (San Diego, CA) and New England 
Biolabs, respectively. Rabbit anti-CPO polyclonal IgG was provided by Dr. Punt. Purified 
oligonucleotide primers were synthesized by MWG-Biotech. Unless otherwise noted, all 
other chemicals and reagents were obtained from commercial sources and used without 
further purification.  
3.1.2 CPO mutant gene construction 
The rCPO expression vector pCPO3.I-AmdS, a plasmid containing the CPO genomic 
clone, was purchased from TNO Nutrition and Food Research Institute, The Netherlands. 
In vector pCPO3.I-AmdS, the cDNA sequence encoding the full-length CPO precursor 
(1122 bp, GenBankTM accession #.AJ300448) is placed under the control of the A. niger 
glucoamylase promoter and A. nidulans trpC terminator. The A. nidulans AmdS selection 
marker was introduced at a unique NotI site. The Amds selection marker encodes 
acetamidase as a dominant nutritional marker. The mutation was prepared by the 
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QuikChange II XL site-directed mutagenesis kit (Stratagene, CA), and introduced via 
PCR amplification of pCPO3.I-AmdS with mutagenic oligonucleotide primers encoding 
an F103A mutation (5' gcc gag ccc cac gct GCC gag cac gac cac tcc 3’). The PCR 
reactions were carried out in a Eppendorf Mastercycler gradient thermal cycler 
(Eppendorf, North American) using the following parameters: initial denaturation at 95 ºC 
for 2 min followed by 18 cycles of 95 ºC for 1 min (denaturation), 60 ºC for 1 min 
(annealing) and 68 ºC for 15 min (elongation). The final touch up PCR step was 68 ºC for 
7 min. The desired mutation was confirmed by DNA sequencing and the expression 
vector pCPO3.I-AmdS containing the F103A mutation was denoted as 
pCPO-F103A-AmdS. 
3.1.3 Plasmid transformation into Aspergillus niger protoplast 
Fungal co-transformation was carried out as described (Punt 1992) using each of the 
expression vectors and pAB4.1 plasmids containing the A. niger pyrG selection marker in 
weight ratio of 10:1. Because the original lysing enzyme Novozym 234 was no longer 
commercially available, the lysing enzyme from Trichoferma harziannum (Sigma S-1412) 
was used. For protoplast production, 1 g of wet A. niger mycelia was incubated with 150 
mg lysing enzyme for 4.5 h in 20 mL of isosmotic buffer. Transformants were selected on 
minimal medium plates containing acetamide as the sole nitrogen source. Transformants 
were further selected for multicopy integration of the expression cassettes on acrylamide 
plates. Extracellular peroxidase activity was screened on o-anisidine plates using 0.05% 
H2O2 in 0.1 M potassium phosphate (pH=3) as developing buffer. 
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3.1.4 Genomic DNA extraction and sequencing 
Spores of A. niger were inoculated and cultured for 2 days in minimal medium. The 
mycelia were collected by centrifugation at 3500 rpm for 20 minutes and re-suspended in 
an isosmotic buffer (1 g/20 mL). The cell wall was then partially digested by incubating 
with lysing enzyme (10 mg/20 mL, Sigma L-1412) for 4 h. The mycelia were again 
collected by centrifugation. DNA extraction was performed with a QIAGEN plant DNA 
mini kit (QIAGEN, CA). The extracted DNA was then used as the template and amplified 
with primers (5'-cgc gga tcc atg ttc tcc aag gtc c -3' & 5'- ccg gaa ttc aag gtt gcg ggc-3’) 
which flanked the CPO coding region. Co-transformants containing the expression 
cassettes were confirmed by the presence of a band at 1122 bp. The extension temperature 
for the PCR reaction was optimized to 56.3 ºC. 
3.1.5 Expression of F103A mutant 
 Fungal culturing was carried out in 2-L Erlenmeyer flasks containing 1 L of A. niger 
minimal growth medium with 5% maltose and supplemented with 0.5% casein amino 
acids. Cultures were inoculated with a whole Petri dish of conidia. After incubation in a 
rotary shaker revolving at 225 rpm for 24 h at 25 ºC, the temperature was lowered to 22 
ºC and the shaking was continued for 6 days. 
3.1.6 Purification of F103A mutant  
 Aspergillus niger crude medium was collected by filtering the fungal culture through 
Miracloth and then centrifuging at 9500 rpm for 1 h, followed by filtration though 0.8 µm 
filters, to further remove mycelia debris. The crude culture medium containing the 
secreted enzyme was concentrated about 200 ~ 400 fold by using a high output 
ultrafiltration cell (10 kDa cut off membrane, Millipore). The condensed medium was 
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dialyzed twice against 25 mM potassium phosphate buffer (4 L) at pH 5.9 for at least 24 
h to adjust the pH and to obtain the proper conductivity. The sample was then applied to a 
DEAE Sepharose fast flow (Amersham) column (2.6 × 20 cm). After an initial wash to 
remove the unwanted protein, the mutant enzyme was eluted from the column by using a 
linear ionic strength gradient of 25 mM potassium phosphate buffer at pH 5.9 containing 
0-0.5 M sodium chloride in 15 bed volumes. The flow rate was adjusted to 1 mL/min. 
The Rz value was used to check the purity of each fraction. Fractions having an Rz value 
greater than 0.6 were collected, then concentrated using a Centriprep-YM30 concentrator 
(Amicon). Further purification was done by gel filtration on a Sephadex G-75 (Amersham) 
column (2.6 × 100 cm) with 50 mM potassium phosphate buffer (pH 4.6, 0.5 mL/min). 
All purification steps were done either using on ice or in a cold box at 4 ºC. 
3.1.7 Western blotting procedure 
The same procedure was used as described for rCPO in section 2.1.5. 
3.1.8 Circular Dichroism spectrum study 
The same procedure was used as described for rCPO in section 2.1.6. 
3.1.9 UV-Visible absorption spectrum study  
All UV-visible absorption measurements were determined in a VARIAN Cary 300 
spectrophotometer using a 1-cm path length quartz cuvette.  
3.1.10 Determination of extinction coefficients of CPO mutant 
In order to determine the extinction coefficient of the Soret band of the F103A 
mutant, both the Wt CPO and the F103A mutant were denatured and then reduced in the 
presence of pyridine and the absorbance of the free ferrous heme complex bound with 
pyridine at 555 nm measured. The mixture contained 166 µL enzyme solution, 600 µL 
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NaOH solution (0.066 N), and 400 µL pyridine. After careful mixing, 10 µL of 1 M 
Na2S2O4 was then added to reduce the heme from ferric to ferrous state. On the basis of 
the known extinction coefficient of Wt CPO (ε398nm = 91200 M-1cm-1), the extinction 
coefficient of the free ferrous heme-pyridine complex was determined (ε555nm = 33.8 
M-1cm-1), which was then used to calculate the extinction coefficient of the F103A 
mutant. 
3.1.11 Activity assays  
1). Chlorination Assay (MCD assay) — the same procedure was used as described 
for rCPO. 
2). Peroxidase Assay (ABTS assay) — the peroxidase’s activity was measured by 
using 2,2'-azino-bis-3-ethyl-benzthiazoline-6-sulfonic acid (ABTS) as the electron donor 
(Yi, Conesa et al. 2003). The 3 mL reaction mixture contained 50 mM phosphate-citrate 
buffer, pH 5.0, 0.01% H2O2, 100 mg/L ABTS, and a suitable aliquot of the enzyme. The 
reaction was initiated by the addition of H2O2, and the increase in absorbance at 405 nm 
was monitored at room temperature. One unit will oxidize 1.0 µmole of ABTS per minute 
at pH 5.0 at 25oC. 
3). Catalase Assay — The 3 mL reaction mixture contained 50 mM phosphate buffer, 
pH 5.0, 4 µL of 35 % H2O2, and a suitable aliquot of the enzyme. The reaction was 
initiated by the addition of enzyme, and the decrease in absorbance at 240 nm was 
monitored at room temperature. 
4). Epoxidation activity and enantioselectivity study — The initial epoxidation rate 
of styrene or its derivatives was determined by monitoring the decrease in absorption at 
242~252 nm with time. The exact wavelength depended on the derivative being analyzed. 
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The 3-mL reaction mixture contained approximately 5 µg of native or mutant CPO, 2 mM 
H2O2, and 300 µM substrate in 100 mM, pH= 5.5 citrate buffer at room temperature (Yi, 
Mroczko et al. 1999). Product yields and enantioselectivity of native and mutant CPOs 
with styrene and its derivatives were determined by HPLC. For these assays, a mixture 
containing 70 µL of styrene or its derivatives, 100 µL of tert-butyl hydrogen peroxide, 
and 400 µL of tert-butanol was first prepared. Then, 250 µL of the above mixture was 
added to 1 mg of wild-type or mutant CPO in 375 µL of 100 mM citrate buffer, pH 5.5. 
The reaction mixture was agitated at room temperature. After 45 min, the reaction was 
stopped by the addition of 50 µL of 1 M Na2S2O3 in a saturated solution of NaHCO3. The 
reaction mixture was extracted with 300 µL of isooctane. The HPLC analysis of the 
extracted organic phase was conducted on a Pirkle Concept WhelkO-1-SS column (2% 
isopropyl alcohol in hexane, 1 mL/min, and UV detector at 214 nm) to determine the 
yield of the reaction and the enantiomeric excess of epoxides (Geigert, Lee et al. 1986). 
5). N-demethylation activity — the reaction mixtures (Kedderis, Koop et al. 1980) 
contained sodium/potassium phosphate buffer (0.5 M), pH 6.0, N,N-dimethylaniline (0.53 
mM), and tert-butyl hydroperoxide (2.1 mM) in a final volume of 3 mL. The reactions 
were initiated by the addition of the enzyme, incubated at 25 °C for 15 min, and 
terminated by the addition of 0.75 mL of 60% trichloroacetic acid. The incubation 
mixtures were extracted twice with ethyl acetate (5 mL) to remove the violet color 
formed during the course of the reaction at higher protein concentrations. To 1 mL of the 
extracted aqueous phase, 0.5 mL of Nash reagent (30 g of ammonium acetate and 0.4 mL 
of 2, 4-pentanedione per 50 mL volume) was added and the solutions were mixed and 
incubated at 25 °C for 45 min. The absorbance of the resulting conjugate was read at 421 
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nm. All experiments were carried out in duplicate or triplicate and included controls in 
which the enzyme was omitted. The data presented are average values. 
3.1.12 Optimum pH for the chlorination activity 
The relationship between activity and pH was examined from pH 2.5 to 7.0 using the 
MCD assay. The phosphate buffer contained 20 mM KCl at each pH value.  
3.1.13 Ligand binding study 
The apparent dissociation constant (Kd) of enzyme and substrate binding was 
determined by the titration method (Dawson, Sono et al. 1983). Enzyme solution (5 μM) 
was prepared in 100 mM phosphate buffer at the appropriate pH and added to a cuvet, 
which was then placed inside a UV-vis spectrometer. A stock solution of the ligand was 
made in the same buffer and added in equal volume to the enzyme solution and the blank, 
which initially contained only the phosphate buffer. The UV-vis spectrum was recorded at 
the beginning and every time an aliquot of the ligand was added until the spectrum 
stopped changing. The Kd was calculated using the formula: 
Kd = [L] (1-v)/v 
Kd is the apparent dissociation constant, [L] is the free ligand concentration and v is the 
ratio of ligand bound enzyme concentration to total enzyme concentration. 
To obtain the ferrous-CO complex of CPO, the [Fe+3] was first reduced to [Fe+2] with 
dithionite and then bubbled for 1 min with carbon monoxide. 
To evaluate the affinity of CPO for a sixth axial ligand, ligands such as cyanide and 
azide, that are known to bind strongly to the heme iron atom, were used and UV-vis 
spectra of the enzyme-ligand complexes were obtained. These ligands would induce a 
change of the heme iron from high spin to low spin (Sono, Dawson et al. 1986). 
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3.2. Results and discussion 
3.2.1 Preparation and purification of F103A mutant 
After successfully expressing rCPO, I prepared a new mutant of CPO, F103A 
employing the same system. Using Stratagene QuikChange II XL site-directed 
mutagenesis kit, a 34 base primer containing the intended mutation was introduced into 
the pCPO3.1-Amds plasmid. After amplification and purification, the PCR product was 
analyzed by agarose gel electrophoresis to verify the vector size and was sequenced to 
verify that the mutation was indeed introduced at the correct location. The new plasmid 
was named pCPOF103A3.1 and was transformed into A. niger strain MGG029 as 
described in Chapter 2. After two rounds of screening based on the uridine dependence, 
ability to use acrylamide and extracellular peroxidase activity, several colonies were 
picked for further investigation. As with rCPO, DNA sequencing was used to confirm the 
presence of the mutant gene in each colony after several rounds of passage of the 
transformed strain to eliminate possible transient transformation.  
One colony was then selected and cultured to produce the mutant protein and the 
mutant protein was purified by the procedure mentioned above for rCPO. The 
chromatography results of purification are shown in Fig. 3.1 & Fig. 3.2. The fractions 
were collected based on the UV-vis absorption at 418 nm (for Soret band) and 280 nm 
(for protein absorption). The fourth peak in Fig. 3.1 and the second peak in Fig. 3.2 were 
identified as heme-proteins and the fractions corresponding to these peaks were collected 
and combined. The purification results are summarized in Table 3.1. With this method, 
more than 8 mg/L active protein can be obtained. Strikingly, the purified F103A CPO 
mutant displayed an Rz value of 1.25, which matched the theoretically calculated value  
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Figure 3.1 Chromatogram of ion exchange chromatography of F103A. 
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Figure 3.2 Chromatogram of gel filtration chromatography of F103A 
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Table 3.1 F103A purification result 
  
Volume 
mL 
Absorbance 
at 418 nm 
Enzyme 
mg 
Yield 
% 
Rz 
A418/A280 
Crude media (condensed) 43 1.934 44.1 100 ND 
Dialysis 27 2.223 31.8 72 ND 
DEAE-Sepharose  60  0.4174 13.3 30 ~0.9 
Sephedex G-75 40  0.3588  7.6 17  ~1.25 
 
Wavelength (nm)
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Figure 3.3 Visible spectra of the free ferrous heme-pyridine complex of F103A mutant 
and Wt CPO. The Soret bands are located at 555, 523, and 478 nm. Based on the known 
extinction coefficient of Wt CPO (ε398 nm = 91200 M-1cm-1) and the calculated extinction 
coefficient of free ferrous heme-pyridine complex (ε555 nm = 33.8 M-1cm-1), the extinction 
coefficient for the F103A mutant was determined. For F103A mutant, ε418 nm = 79200 
M-1cm-1, and the Rz value = 1.25. 
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Figure 3.4 15% SDS-PAGE result of F103A purification. Lanes 1&7 are protein 
molecular weight markers. Lanes 2 to 4 are F103A samples from crude media, and ion 
exchange and gel filtration purification steps, respectively. Lane 5 is the sample of Wt 
CPO and lane 6 is a mixed sample of Wt CPO and purified F103A. According to the gel 
result, the molecular weight of the F103A mutant is sightly smaller than that of Wt CPO. 
 
 
 
 
Figure 3.5 Western blotting analysis result: Lanes 1 to 3 are F103A, Wt CPO, and rCPO 
respectively. Proteins were detected with an anti-CPO polyclonal antiserum. The 
antibody was diluted 1:10K for F103A, and 1:100K for Wt and rCPO. 
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for F103A using the pyridine hemochromagen method (Fig. 3.3). The calculated 
extinction coefficient for F103A at 418 nm equals to 79200 M-1cm-1, and the pure form of 
protein is supposed to has an Rz value equals to 1.25. The protein fractions from each 
purification step and the final product were analyzed by SDS-PAGE to determine its 
purity (Fig. 3.4). In addition, the authenticity of the product was examined by western 
blotting (Fig. 3.5). As seen in the SDS-PAGE and western blotting, the molecular weight 
of F103A is apparently smaller than that of either rCPO or Wt CPO, probably because of 
a different glycosylation profile. The molecular difference may indicate a possible 
conformational change causing the amino acid side chains exposed on the protein surface 
to have changed, thus altering the glycosylation profile. However, due to the difficulty 
caused by the heavy glycosylation with both N- and O-glycosylation, I was unable to 
identify the differences in glycosylation. Nonetheless, the western blotting with rabbit 
anti-CPO polyclonal antibody confirmed that the purified protein is indeed a CPO 
mutant.  
3.2.2 Structure and function study of F103A mutant 
Heme proteins have characteristic visible Soret absorption bands that convey 
significant information about the structure and coordination state of their active sites. The 
UV-vis spectrum of F103A, Wt CPO, and P450 camphor were examined and compared 
in Fig. 3.6. The UV-vis spectrum of F103A was quite different from that of Wt CPO, yet 
resembled that of camphor free P450cam (CYP101). The major Soret band for Wt CPO is 
at 398 nm and the corresponding band for the mutant is at 418 nm. The α and β bands of 
Wt CPO are at 514 nm and 539 nm; the corresponding bands for the mutant are at 
539 nm and 573 nm. Both the major Soret band and the minor bands of F103A mutant are 
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all at the positions that are very similar to P450cam, which has bands at 417, 536, and 
569 nm. 
One similarity between Wt CPO and P450cam is that they have a cysteine as the 
proximal ligand for the heme center. To verify that such a structural feature was retained 
in the F103A mutant, the UV-vis spectral properties of the protein-CO complex of these 
enzymes under reducing condition were studied (Fig. 3.7). The ferrous-CO complex of 
heme containing enzymes with a thiol group as the proximal ligand shows a distinctive 
Soret band near 450 nm. The spectrum of F103A CPO-CO complex was essentially 
identical to that of Wt CPO-CO and P450-CO, confirming that F103A also has a thiol 
proximal ligand. 
These spectral features are summarized in Table 3.2 and indicate that although 
F103A has the same proximal ligand as Wt CPO; F103A has different structural features 
around the heme center. It is most probable that these differences are caused by change 
on the distal side. The close resemblance of F103A and P450cam indicates that F103A 
may have a water molecule as the sixth ligand, like P450cam. Unlike in Wt CPO, the 
water molecule in the active center does not bind to the ferrous center directly, but only 
binds with Glu183 by hydrogen bond. These changed will affect ligand binding, substrate 
selection, as well as catalytic behavior of the enzyme; it makes F103A a much better 
model for p450. The structural basis for this change is worth further exploration. There is 
a slight possibility that the changes were the result of an overall structural reconfiguration. 
A nearly identical CD spectrum (Fig. 3.8) showed that, like rCPO, there is no significant 
secondary structural change in F103A compared to Wt CPO. 
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Figure 3.6 UV-vis spectra of Wt CPO, and its F103A mutant in 0.05 M potassium 
phosphate buffer, pH 5.0, and P450cam in 0.05 M potassium phosphate buffer, pH 7.4. 
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Figure 3.7 UV-vis spectra of the ferric, ferrous, and ferrous-CO complexes of the F103A 
mutant in 0.05 M potassium phosphate buffer, pH 5.0
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Table 3.2 Spectral properties of heme thiolate proteins (P450cam, Wt CPO and CPO F103A mutant) and their ligand complexes 
 
Protein λmax, nm (ε, mM-1•cm-1) reference 
 δ Soret β α CT  
Ferric substrate free 
CPO F103A 356 418 (79.2) 538 (8.5) 572 (7.5) 637 (2.2) this work 
Wt CPO  398 (91.2) 514 (13.0) 543 (11.5) 651 (4.4)  
Wt P450cam 365 417 (115) 536 (10.6) 569 (11.1) na (Dawson, 
Andersson et al. 
1982) 
 
Ferrous ligand free 
CPO F103A  405 (60.6) 547 (10.5)   This work 
Wt CPO  408 (79.3)  550 (12.7)   This work 
Wt P450cam  408 (87.1) 540 (15.8)   This work 
       
Ferrous-CO complex 
CPO F103A  443 (71.7) 552 (9.7)   This work 
Wt CPO  446(124.8) 550 (11.2)   This work 
Wt P450cam  446(130.6) 550 (16.3)   This work 
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Figure 3.8 The CD spectra of F103A mutant (0.375 µM in 10 mM phosphate buffer 
pH=6) and Wt CPO (0.3 µM in 10 mM phosphate buffer, pH=6). The experiments were 
carried out at the room temperature and recorded from 190 to 250 nm. The path length 
was 1cm.  
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Figure 3.9 Relative activities of Wt CPO, C29H, F103A and E183H mutants.
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Figure 3.10 Catalase activity assays of Wt CPO and F103A.  
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Figure 3.11 N-demethylation activities of Wt CPO and its F103A mutant.  
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Naturally, I am interested in understanding how these structural changes affect the 
protein’s catalytic properties. A comparison of the chlorination, epoxidation, peroxidation 
and dismutation activity of the wild type, F103A mutant, and other CPO mutants is 
shown in Fig. 3.9. The chlorination activity of the mutant enzyme decreased to 1% of the 
wild type activity, so did the dismutation activity, and the catalase activity decreased to an 
undetectable level (Fig. 3.10). Peroxidation and epoxidation activity, however, 
unexpectedly increased by 10-fold, and 4-fold, respectively. Similarly, an increase of 5.6 
fold in the N-demethylation activity was observed for this mutant CPO (Fig. 3.11). 
These data show that the F103→A mutation changes the catalytic activity of CPO 
dramatically. As mentioned in the introduction, once the CPO reacts with hydrogen 
peroxide and forms Cpd I, it has three pathways to return to the resting state: (1) react 
with another molecule of polar substrate with high redox potential like peroxide or 
chloride, generating O2 or a reactive oxygen species like HOCl; (2) return to resting state 
by two one-electron steps, lose one redox equivalent and be reduced to Cpd II, a 
nonradical oxoferryl species, then oxidize another substrate and return to the resting state; 
(3) lose two electron equivalents by inserting its oxoferryl oxygen into a suitable acceptor 
in a P450 type reaction. 
After examination of the catalytic activities of F103A, it becomes evident that 
pathway (1) is inhibited, whereas pathways (2) and (3) are enhanced as reflected by the 
decrease in catalase and chlorination activity but an increase in peroxidase, epoxidation 
and N-demethylation activity. Two plausible explanations for the results are that F103A 
Cpd I has a lower redox potential, and thus is unable to oxidize reactants with higher 
redox potentials; and that the F103A catalytic center does not react with polar substrates 
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favorably, thus lowering the reactivity with hydrogen peroxide and chloride ion. A 
combination of both is also possible; however, further studies are required. 
The dramatic changes in the activity profile of F103A CPO actually make it a better 
industrial catalyst than Wt CPO. Epoxidation of alkenes, chloroalkenes, styrene, and 
other chemicals is an important type of reactions used in drug synthesis (Neidleman and 
Geigert 1983; Lakner and Hager 1996). Higher activity will certainly preferred for a 
catalyst used in these areas. In Wt CPO, the epoxidation pathway has to compete with 
catalatic pathway; a lower catalase activity will help to improve the epoxidation activity 
and conversion rate especially with higher hydrogen peroxide concentration (Manoj and 
Hager 2001)  
To gain insight into the structural changes of the active site, the UV-vis spectrum of 
F103A was acquired at each of several pH values. As the pH is lowered down to 3, a 
shoulder peak at 400 nm became more prominent (Fig. 3.12), indicating the presence of a 
high spin ferric center, similar to that found in Wt CPO from pH 2 to 7. The five 
coordinate high spin state of F103A could be produced by the loss of water from the 
six-coordinate low spin state. As the pH is lowered, water has a lower binding affinity for 
F103A and tends to disassociate from the heme center converting the ferric center of 
F103A from a six coordinate low spin state to a five coordinate high spin or mixed spin 
state. In the mixed spin state some of the iron atoms are high. This further proves that the 
F103A CPO mutant, like P450cam, has a water molecule served as the sixth ligand of the 
heme center at its resting state. Similar spectral changes are also observed when P450 
binds a molecule of camphor, which results in the loss of water as the sixth ligand 
completely (Dawson, Andersson et al. 1982). 
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Figure 3.12 UV-vis spectra of F103A in 0.1 M potassium phosphate buffer at pH 3. At 
pH=3, the F103A mutant has a shoulder peak around 400 nm. 
 
The ligand binding properties of F103A with a variety of ligand were investigated to 
probe the chemical environment of the heme center in this CPO mutant. A wide range of 
ligands with different pKa values and different coordinating atoms were employed. The 
spectrums of each F103A-ligand and Wt CPO-ligand complex are presented here: 
cyanide (Fig. 3.13), azide (Fig. 3.14), imidazole (Fig. 3.15), thiocyanate (Fig. 3.16), 
formate (Fig. 3.17), and acetate (Fig. 3.18). Both Wt CPO and its F103 mutant showed 
very similar absorption spectrum when binding to the same ligand, indicating the heme 
center in F103A has a similar configuration to Wt CPO when binds to a ligand, thus it 
may adopt similar intermediates and mechanism during catalysis. The only exception is 
acetate; unlike in Wt CPO, it binds to the ferric center and gives a mixed spin state for the 
heme center (Sono, Dawson et al. 1986), in F103A, the heme center remains its original 
low spin state, in addition to no shift in Soret band position shift was observed. 
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Figure 3.13 UV-vis absorption spectra of the cyanide complexes of ferric Wt CPO and 
F103A. The spectra were obtained at pH=3 in 0.1 M potassium phosphate buffer at room 
temperature with 5 µM enzyme concentration. The ligand concentrations were 0.2 M for 
F103A mutant, and 20 mM for Wt CPO 
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Figure 3.14 UV-vis absorption spectra of the azide complexes of ferric Wt CPO and 
F103A. The spectra were obtained at pH=3 in 0.1 M potassium phosphate buffer at room 
temperature with 5 µM enzyme concentration. The ligand concentrations were 35 mM for 
F103A mutant, and 13 mM for Wt CPO. 
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Figure 3.15 UV-vis absorption spectra of the imidazole complexes of ferric Wt CPO and 
F103A. The spectra were obtained at pH=6 in 0.1 M potassium phosphate buffer at room 
temperature with 5 µM enzyme concentration. The ligand concentrations were 2 M for 
F103A mutant, and 4 M for Wt CPO. 
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Figure 3.16 UV-vis absorption spectra of the thiocyanate complexes of ferric Wt CPO 
and F103A. The spectra were obtained at pH=3, in 0.1 M potassium phosphate buffer at 
room temperature with 5 µM enzyme concentration. The ligand concentration was 100 
mM for F103A mutant, and 15 mM for Wt CPO.   
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Figure 3.17 UV-vis absorption spectra of the formate complexes of ferric Wt CPO and 
F103A. The spectra were obtained at pH=3 in 0.1 M potassium phosphate buffer at room 
temperature with 5 µM enzyme concentration. The ligand concentration was 1.5 M. 
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Figure 3.18 UV-vis absorption spectra of the acetate complexes of ferric Wt CPO and 
F103A. The spectra were obtained at pH=3 in 0.1 M potassium phosphate buffer at room 
temperature with 5 µM enzyme concentration. The ligand concentration was 2 M. 
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Table 3.3 Optical absorption data, dissociation constants, and spin states of ferric Wt CPO & ferric F103A CPO mutant ligand 
complexs
a
  
 
Ligand 
Pka of 
Ligand
b
 
absorption maxima
c
 [λ (εmM)]   Kd
app 
(mM) Kd
int d 
(mM) 
spin 
state Enzyme name δ Soret  β α     pH=3   
KCN Wt CPO 
9.14 
366 (45.4) 439 (92.3) 557 (13.0)       0.14 0.14 low 
F103A CPO 361 (35.9) 436 (56.1) 556 (8.5)       0.27 0.27 low 
KN3 Wt CPO 
4.72 
365 (37.6) 431 (85.5) 544 (11.3) 580 (7.8) 642 (3.0) 1.3+0.2
 
 1.3 low 
F103A CPO 360 (46.1) 428 (64.3) 548 (10.3) 583 (7.5) 647 (2.1)   2.9+1.4
 
 1.8 low 
KSCN Wt CPO 
-1.90 
365 (36.8) 430 (90.3) 548 (11.4) 585 (6.4) 649 (1.4)   0.09+0.01
 
 e low 
F103A CPO 366 (40.6) 426 (64.5) 543 (9.4) 575 (6.4) 646 (1.6)   6+4 e low 
Imidazole Wt CPO 
7.00 
367 (37.8) 428 (93.3) 545 (12.8) 580 (7.5) 644 (1.5)   e e low 
F103A CPO 358 (40.0) 427 (107.1) 545 (12.8) 575 (8.1)     e e low 
HCOOK Wt CPO 
3.75 
358 (30.1) 424 (99.6) 544 (9.4) 581 (8.3) 637 (2.9)   0.62 0.53 low 
F103A CPO 360 (35.1) 421 (68.3) 541 (8.2) 574 (7.1) 637 (2.8)   102 87 low 
CH3COOK Wt CPO 
4.77 
  411 (79.7) 540 (7.6) 583 (6.0) 638 (4.8)   e e mix 
F103A CPO 358 (32.8) 419 (86.1) 538 (9.5) 574 (8.5) 638 (2.4)   e e low 
 
a All data were abtained in 0.1 potassium phosphate buffer at pH 6 or pH 3 at room temperature. b pKa values for the ligands are 
taken from the following literature: (i) (Danehy and Parameswaran 1968); (ii) (Perrin, Dempsey et al. 1981); (iii) (Streitwieser 
1981). c The λ and εmM expressed in nm and mM-1cm-1, respectively. d Intrinsic (int) affinity for the neutral form of the ligands (see 
text). e Not determined. 
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Table 3.4 Apparent Kd for cyanide binding of Wt CPO and F103A at various pH 
pH value F103A Wt CPO 
pH=3  268.0 μM 141.5 μM 
pH=4  298.0 μM 151.7 μM 
pH=5 4236.8 μM 165.7 μM 
pH=6 4481.7 µM 90.33 μM 
 
The apparent Kd values (Kd) for ligand binding of several ligands were derived from 
the ligand binding studies (Table 3.3). Generally F103A shows lower affinity for ligands 
than Wt CPO, an effect that can be accounted for by a more opened active center 
allowing more freedom of the ligand in F103A, plus the ligand has to compete with a 
H2O molecule that served as the sixth ligand, while in Wt CPO, a H2O is 3.5 Å away 
from the heme center. The binding affinity of the F103A for cyanide and azide decreased 
2 fold, and for two of the more acidic ligand, thiocyanate, and formate decreased 
dramatically (100 fold). The extent of decrease was hard to determine for acetate because 
it has a very low affinity for Wt CPO and any significant decrease will cause its binding 
with F103A to become undetectable. However the extent of the decrease is not correlated 
with pKa values, it is possible that the structure of the ligand may also play a role here.  
The effect of pH on the ligand binding of the F103A mutant to one of the strongest 
ligands, cyanide (Table 3.4). Compared to Wt CPO, which has a small increase in the 
ligand affinity between pH 5~6, F103A actually showed an abrupt decrease in ligand 
affinity between pH 4~5. A similar effect was observed when studying the chlorination 
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activity of F103A, unlike Wt CPO that has an optimum pH=2.75, F103A mutant has an 
optimum pH=3 (Fig. 3.19). 
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Figure 3.19 pH profiles for chlorination activity of Wt CPO and F103A. 
 
One possible explanation for such changes could be changes of the distal ligand state. 
It had been well established that Glu183 plays an important role in stabilizing the 
ligand-ferric heme iron complex (Sundaramoorthy, Terner et al. 1998; Kuhnel, 
Blankenfeldt et al. 2006). It is possible that Glu183 may not be suitably close enough to 
the ferric center to form a hydrogen bond with the ligand, or the hydrogen bond network 
formed by Glu183, His105 and Asp106 had been interrupted. Thus instead of Glu183, Ser 
184 is placed close to the ferric center, adopting a similar configuration to P450cam. 
Another possible scenario is that the F103A mutation causes a slight twist of the peptide 
backbone where F103 is located, disrupting the nearby hydrogen bond between His105 
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and Glu183, resulting in the formation of a new hydrogen bond between Asp106 and 
Glu183. On the basis of significant decrease in cyanide binding between pH 4-5 and the 
decrease in optimum pH of chlorination, the latter hypothesis is more plausible.  
3.2.3 F103A mutant as a possible industrial catalyst 
As mentioned in the introduction, one drawback of Wt CPO is its limited ability to 
accept larger substrate, thus substituting the Phe103 with a smaller amino acid, Ala, 
should change the structure of the active center to allow access of larger substrate. To 
evaluate this approach, a series of styrene derivatives were used to study the catalytic 
activity of the F103A mutant.  
Although Wt CPO can catalyze the epoxidation of α-methylstyrene and 
α-ethylstyrene (Dexter, Lakner et al. 1995), with high enantioselectivity, the turnover 
number decreased dramatically as the substituent group was changed from methyl to 
ethyl; a similar phenomenon was also observed when comparing α-methylstyrene and 
styrene. It is proposed that repositioning the methyl or larger substituent group on the 
double bond of the styrene might offer insights into the steric control of both reactant size 
and reaction enantioselectivity. Furthermore, styrene and its derivatives are an important 
group of compounds for industrial applications, yet are challenging to modify with 
enzymes. In addition, the aromatic group will enable assessment of the reaction with 
UV-vis spectroscopy.  
 The epoxidation behavior of F103A on styrene derivatives with increasing size of the 
substituent on alpha carbon of the double bond was investigated: α-methylstyrene, 
α-ethylstyrene, and α-propylstyrene. An increase in catalytic activity with both 
α-ethylstyrene and α-propylstyrene (Fig. 3.20) was observed for F103A, both substrate 
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react very slow with Wt CPO and required prolonged time (~1 h) for a noticeable change 
to occur by UV-vis. Styrene derivatives with a more highly substituted group on the 
double bond was also used as substrates. While Wt CPO reacts poorly with tri-substituted 
styrene, F103A can accept such substrates with higher turnover rates. However, 
tetra-substituted styrene was accepted as a substrate by neither Wt CPO nor F103A (Fig. 
3.21). The next structural feature we studied was the conformation of the substrate. Trans 
derivatives of styrene and trans olefins, in general, were found to be poor substrates for 
Wt CPO, as is usually the case in epoxidation reactions catalyzed by heme proteins and 
their synthetic models (Groves and Nemo 1983). However, F103A can catalyze the 
epoxidation of trans-β-methylstyrene (Fig. 3.22), and trans-substrates with larger 
substituent, such as trans-1-phenyl-1-pentene and trans-1-phenyl-1-butene. 
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Figure 3.20 UV absorbance decrease at 242 nm profiles for F103A (39 nM) catalysis of 
the epoxidation of α-methylstyrene, α-ethylstyrene, and α-propylstyrene (300 µM) in 100 
mM citrate buffer, pH = 5.5. 
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Figure 3.21 UV absorbance decrease at 243 nm profiles for F103A (39 nM) catalysis of 
the epoxidation of 2-methyl-phenyl-1-propene and 1,2-dimethyl-propenyl-benzene (300 
µM) in 100 mM citrate buffer, pH = 5.5.  
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Figure 3.22 UV absorbance decrease at 250 nm profiles for F103A (39 nM) catalysis of 
the epoxidation of trans-β-methylstyrene, trans-1-phenyl-1-butene, and 
trans-1-phenyl-1-pentene (300 µM) in 100 mM citrate buffer, pH = 5.5. 
Time ( minute )
0.0 0.2 0.4 0.6 0.8 1.0 1.2
A
bs
or
ba
nc
e 
( 2
43
 n
m
)
0.2
0.4
0.6
0.8
1.0
1.2
1.4
2-methyl-1-phenyl-1-propene
1,2-dimethyl-propenyl-benzene
 
 
79 
 
Lastly, the enantioselectivity of F103A with these substrates was examined. Chiral 
HPLC with an UV detector was used to study the epoxidation products of various styrene 
derivatives. A sample HPLC trace is shown in Fig. 3.23 & Fig. 3.24. In these figures, It 
can be seen that the F103A mutant has almost completely lost its enantioselectivity when 
catalyzing styrene epoxidation, in contrast to Wt CPO which has an ee% of 49. For other 
substrates that can be accepted by both Wt CPO and F103A, F103A showed a distinctive 
enantioselectivity profile (Table 3.5). Similar to styrene, F103A almost lost its 
enantioselectivity when catalyzing the epoxidation of cis-β-methylstyrene. However, 
when catalyzing another substrate that reacts readily with Wt CPO, α-methylstyrene, 
F103A showed high enantioselectivity but with a different configurational In summary, 
on the basis of the NMR data, rCPO and Wt CPO have very similar active site structures. 
The 1D and 2D spectra are nearly identical, as are the T1 values and the intercepts of the 
Curie plots. The chemical shifts of the paramagnetically shifted resonances in isozyme B 
of Wt CPO and the corresponding resonances in rCPO are at most 0.4 ppm apart with the 
exception of the resonance at approximately 39 ppm, which is broad and has a poorly 
defined peak, Table 2.3. For comparison, when yeast cytochrome c, a non-glycosylated 
heme protein was expressed in E. coli, the chemical shifts of the paramagnetically shifted 
resonance of wild type and recombinant proteins differed by up to 0.6 ppm preference. 
When catalyzing larger, more branched substrates, trans-β-methylstyrene, 
trans-1-phenyl-1-butene, and 2-methyl-phenyl-1-propene, F103A exhibited higher 
enatioselectivites and higher conversion rate.  
The new enantioselectivity profile can be explained by the steric control of substrate 
access to the ferric center and the configuration inside the heme pocket. When F103 is  
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Figure 3.23 Chiral HPLC trace of the products obtained from the epoxidation of styrene 
catalyzed by Wt CPO. 
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Figure 3.24 Chiral HPLC trace of the products obtained from the epoxidation of styrene 
catalyzed by F103A. 
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Table 3.5 Enantioselectivity study of F103A catalyzed of epoxidation reactions 
Substrate            Major product          ee (%)a          Yield (%)   
  
 
a enantiomeric excess (ee%)  
 
replaced by Ala, it creates a larger opening within the heme pocket. Thus, when styrene 
derivatives enter the heme pocket of F103A, the substrates have more freedom compared 
to Wt CPO. A model of styrene binding to Wt CPO indicates close proximity between the 
alpha-carbon of styrene and F103. Therefore, the alpha-substituted styrenes have to adapt 
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a configuration that allows them to avoid Phe103 and Phe186, resulting in a lower 
reaction rate and a different orientation of the double bond next to the catalytic center. 
Other more branched styrene derivatives can enter the heme pocket in F103A, but have a 
much greater difficulty entering the Wt CPO heme pocket. Once the styrene derivative 
enters the heme pocket, a conformation that allows it to be in a close proximity to the 
ferric-oxo catalytic center has to be adapted, thus leading to enantioselective oxygen 
insertion reactions. 
Furthermore, the heme pocket of F103A must be wider and maybe deeper than that 
of Wt CPO, as it can accommodate trans-substituted styrenes and other styrene 
derivatives with larger or more substituted double bonds. This may be because the 
alpha-helix where the F103 is located adopts a slightly different orientation when F103 is 
substituted with Ala.  
3.3 Conclusion 
In F103A mutant, a Phe located at the opening of the heme pocket was replaced by a 
small hydrophobic amino acid, Ala. The mutant displayed very desirable features 
compared to Wt CPO. One significant improvement is F103A’s lack of catalase activity. 
Catalase pathway compete with monooxygenase pathway in CPO, lower catalase activity 
will help to improve the desired activities like epoxidation increased; indeed, epoxidation 
activity of F103A increased by 4-fold. Another important change was F103A’s ability to 
catalyze the epoxidation of many styrene derivatives with high enantioslectity that are 
poor substrates for Wt CPO. Styrene and its derivatives are an important group of 
substrates with important industrial applications (Hager, Lakner et al. 1998). F103A can 
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be served as a very promising candidate as an industrial catalyst due to its special 
substrate specificity and enatioselectivity. 
It is very intriguing that a simple replacement of a single amino acid outside the 
catalytic center can cause such dramatic changes in the catalytic profile of CPO. 
Phenylalanine 103 was originally proposed to regulate substrate access to the catalytic 
center, although this hypothesis proved to be valid, by the study of its epoxidation of 
styrene derivatives, it is somewhat unexpected that it can act as a switch to turn on and 
off many of the Wt CPO’s activities.  
A look at the primary sequence and secondary structure of CPO tells us that Phe103 
is located at the end of a hydrogen bonded turn and at the beginning of an undefined loop 
that consists of a series of polar amino acid ranging from Glu104 to Tyr114. It contains 
Glu104-His105-Asp106-His107-Ser108-Phe109-Ser110-Arg111-Lys112-Asp113-Tyr114 , 
and forms part of the wall and ceiling of the heme-pocket as revealed by the X-ray 
structure of Wt CPO (Sundaramoorthy, Terner et al. 1995). Two of these amino acids, His 
105 and Asp106, were proposed to form a hydrogen bond network with Glu183 to 
facilitate the formation of Cpd I and ligand binding.  
Since there are no significant structural changes in F103A as indicated by the CD 
spectroscopy study, one possible explanation for the importance of Phe103 is that the 
replacement of F103 by A caused subsequent conformation changes in this undefined 
loop structure, including perturbation of the hydrogen bonded network formed by His105, 
Asp 106 and Glu183. Since cyanide binding affinity undergoes significant decrease 
between pH 4-5, it is suspected that another acidic amino acid side chain is still involved 
with Glu183, if it remains in the same position as in Wt CPO. One possible candidate is 
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Asp106. Another possible scenario is that more dramatic changes have caused Glu183 to 
move away, and another amino acid side chain has repositioned to react with the water 
molecule. Judging from the optimal pH and ligand binding affinity of F103A, the amino 
acid would still be an acidic amino acid side chain like Glu or Asp. By analyzing the 
crystal structural of Wt CPO, such relocations would have caused significant overall 
structural changes, thus the latter scheme is unlikely to happen. 
The F103A is a very interesting mutant as it provides greater enzymatic activities and 
several clues on how CPO regulates its catalytic activity. Since it has a greater 
resemblance to P450cam in its UV-vis spectrum; F103A is a better model to understand 
the long standing yet difficult question of P450 mechanism than CPO. Future studies on 
F103A, with more site-directed mutagenesis, spectroscopic and kinetic studies, will help 
us to elucidate the structural basis of its attractive features and the mechanism underlying 
them. It will also facilitate the study of P450cam and other related heme-containing 
peroxidase.  
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Chapter IV 
C29H/C79H/C87H CPO Mutant Purification and Characterization 
4.1 Material and methods 
4.1.1 Strains and reagents 
The same procedure was used as described for F103A in section 3.1.1; except that A. 
niger strain ATCC 62590 (pyrG deficiency) was bought from American type culture 
center (ATCC) and was used as the expression host. The strain carries a nonfunctional 
pyrG gene, which enables the use of the pyrG selection marker. Recombinant CPO was 
expressed successfully in our laboratory using A. niger strain ATCC 62590 as host strain. 
4.1.2 CPO mutant gene construction of expression plasmid 
The same procedure was used as described for F103A in section 3.1.2, except that 
three different primers were used to introduce the triplet mutation into CPO. The three 
primers were C29H-anti: gac tct cgt gct cct CAC cca gct ctg aac gct c, C79H-anti: c aac 
gcc ttc gtc gtc CAC gag tac gtt act ggc and C87H-anti: gtt act ggc tcc gac CAT ggt gac 
agc ctt gtc. After each mutation was confirmed by DNA sequencing, the resulting plasmid 
was then used as the template for the next mutation. The CPO expression vector with the 
triple mutations was named pCPO#3C. 
4.1.3 Plasmid transformation into A. niger protoplast  
Fungal co-transformation was carried out as described in section 3.1.3, using the 
CPO expression vector pCPO#3C and assistant plasmids pAB4.1, which contains the A. 
niger pyrG selection marker in a weight ratio of 10:1.  
4.1.4 Genomic DNA extraction and sequencing 
The same procedure was used as described for F103A in section 3.1.4 
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4.1.5 Expression of C29H/C79H/C87H CPO mutant 
The same procedure was used as described for F103A in section 3.1.5  
4.1.6 Total mRNA extraction and reverse transcription PCR  
Aspergillus niger culture medium was collected after 48 h of growth then filtered. 
The A. niger mycelia were washed with sterile water and then grinded in liquid nitrogen 
to a fine power. The grinded power, 50 mg, was either stored in a -70oC freezer for 
further study or used directly. Total mRNA was extracted with a QIAGEN plant mRNA 
kit. The extracted total mRNA was then converted into cDNA via reverse transcription 
PCR (RT PCR). The RT PCR mixture contained, 5 µL of mRNA sample as template, 
0.75 µL of a blend of random hexameric RNA primers, 0.25 µL of anchored oligo dT 
RNA primers, 1 µL of RT enhancer, 1 µL of reverse transcription DNA polymerase, 2 µL 
of dNTP mix, 4 µL of 5X PCR buffer and 4 µL of water. The extension PCR step was 
performed at 56 ºC for 30 min. The cDNA sample was then used as the template to 
undergo a second PCR reaction using primers 5'-cgc gga tcc atg ttc tcc aag gtc c -3' and 
5'- ccg gaa ttc aag gtt gcg ggc-3’ to amplify the CPO coding region. A PCR fragment size 
of 1122 bp was used to confirm positive CPO mRNA transcription. 
4.1.7 Western blotting procedures 
The same procedure was used as described for F103A in section 3.1.7 
4.2 Results and discussion 
One unique feature that separates CPO and P450 from other peroxidases is the 
proximal ligand, which is the fifth ligand to the ferric center of the heme. In CPO, the 
proximal ligand is a cysteine, instead of the usual histidine. A previous report about C29H 
expressed in C. fumago showed that replacement of the proximal amino acid Cys29 with 
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histidine had no significance effect on enzymatic activity (Yi, Mroczko et al. 1999) Given 
the surprising result, I suspected that another cysteine was involved as the proximal 
ligand or contamination from endogenous Wt CPO in the parental host. With these 
questions in mind, I attempted to create a new CPO mutant C29H/C79H/C87H in which 
all of the cysteines in CPO were replaced by histidine.  
The experimental approach is basically the same as for the F103A CPO mutant. I 
designed the primers and introduced the three mutations to the transformation vector one 
by one. The vector was then sequenced to verify that the mutations were introduced 
correctly and that no other bases had been altered. The new vector was named pCPO#3C. 
I then proceeded to co-transform of pCPO#3C and pAB4.1 into A. niger strain ATCC 
62590, the parent strain of MGG029. The MGG029 strain was used to produce rCPO and 
F103A as decribed in earlier chapters. After uridine and acrylamide selection, PCR 
confirmed that a positive clone had been selected and RT-PCR was then undertaken to 
confirm that the CPO gene was transformed and transcripted (Fig. 4.1).  
However, when I proceeded to purify the mutant protein, I found neither detectable 
extracellular peroxidase activity nor a visible protein band between 40 to 50 kDa on the 
SDS-PAGE gel. Therefore I extracted not only the extracellular protein secreted by A. 
niger, but also the cellular protein of A. niger as well for immunizing detection. A 
western blot showed no reaction between the polyclonal CPO antibody and a protein of 
the correct size (Fig. 4.2), although, some broad bands did appeared. I reasoned that the 
three mutations had dramatically changed the protein conformation, thus, the product 
protein lost structural similarity to CPO and maybe also the ability to incorporate heme, 
since no peroxidase activity was detected. Other possible explanation are that the mutant 
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B. 
 
Figure 4.1 Confirmation of positive transformation and transcription of 
C29H/C79H/C87H mutant. A. PCR results on extracted genomic DNA sample to 
confirm positive transformation. A.niger stain ATCC 62590 was transformed with 
plasmids pCPO#3C and pAB4.1. B. RT-PCR & cDNA PCR results. RT-PCR was done 
on extracted mRNA sample of A. niger strain B3C#1-3. The second PCR were done on 
the cDNA sample synthesized in the RT-PCR to confirm positive CPO gene 
transcription. NC and PC are the abbreviation of negative and positive control 
respectively.  
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  A                                      B 
Figure 4.2 Western blotting analysis on extracted both cellular and extracellular protein 
samples from A. niger strain (ATCC 62590) transformed with CPO expression vector 
pCPO#3C to detect CPO mutant expression. A. Total extracellular protein; B. Total 
cellular protein.  
 
protein was expressed but partially digested by protease or wrongly folded, which caused 
the unclear, broaden bands in the western blot. Similar phenomenon were observed with a 
CPO mutant with a truncated C-terminal gene (Conesa, Weelink et al. 2001). 
4.3 Conclusion 
Although, successful transformation and transcription was confirmed for the 
C29H/C79H/C87H mutant, no active protein could be isolated or detected in the culture 
media, indicating that a complete structural rearrangement have taken place in this 
mutant. Cystine 29 is undoubtedly an important amino acid served as the proximal ligand 
for the ferric heme center in Wt CPO. Surprisingly no dramatic change but some decrease 
(about 20%) in activity was observed in the C29H mutant (Yi, Mroczko et al. 1999) My 
results suggest that Cys79 and Cys87 are critical to maintaining the structural scaffold of 
CPO. According the CPO crystal structure (Sundaramoorthy, Terner et al. 1995), Cys79 
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and Cys87 are close enough to form a disulfide bond and are located in the middle of an 
alpha-helix. Apparently disrupting the disulfide bond, results in the collapse of the protein 
scaffold and loss of its active conformation. Thus, it is very unlikely that in C29H mutant, 
another Cys was recruited as the proximal ligand for the heme-center. Therefore my 
results supports the findings made in the C29H study that cysteine is not required for Wt 
CPO activity although its ligation to ferric center facilitates the cleavage of O-O bond to 
form Cpd I. It will be interesting to see if replacement of C29 with another amino acid 
like tyrosine would cause a different scenario. Ultimately, the distal amino acid forming 
the substrate binding pocket above the heme center may play a significant role in 
regulation CPO’s enzymatic activities. 
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Chapter V 
In vitro biodegradation of carbon nanotube by CPO 
5.1 Material and Methods 
5.1.1 Reagents  
 Electric arc discharge single wall nanotubes (SWNTs) were purchased from Carbon 
Solutions, Inc. All other reagents were purchased from Sigma-Aldrich. Wt CPO was 
purified in Dr. Xiaotang Wang’s laboratory. 
5.1.2 Nanotube biodegradation by CPO and H2O2                   
 Purchased SWNTs were further purified by oxidative treatment with H2SO4 /H2O2 to 
remove residual metal catalyst, to impart carboxylic acid groups, and to break down the 
size of the SWNTs to shorter pieces (500~600 nm), thus improving solubility in aqueous 
media.  
 Nanotubes (2 mg) were suspended in 4.5 mL of 0.1 M phosphate buffer at pH 3 or 5 
using an ultrasonic bath for 1 min (Branson 1510, frequency 40 kHz). Purified CPO (1 
mg/mL) was dissolved in 0.1 M phosphate buffer (pH 3 or 5), and then 4.0 mL was added 
to the carboxylated nanotubes suspended in the same buffer. The entire suspension was 
then statically incubated for 24 h at 4 °C in the dark. Hydrogen peroxide, 10.0 mL of a 
160 µM solution in 0.1 M phosphate buffer at the corresponding pH, either 3 or 5, was 
added to the bulk sample to start the catalytic biodegradation of carbon nanotubes in the 
presence of CPO. Static incubation with H2O2 was performed at 4 °C in the dark to avoid 
enzyme denaturation and photolysis of H2O2.  
 Over the incubation period, daily measurements of H2O2 concentration were 
performed, and fresh H2O2 was added to bring the total concentration back to the initial 
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concentration. Furthermore, the absorbance of the mixture at 398 nm was determined 
biweekly and fresh CPO was added to maintain the CPO concentration, if necessary. 
5.1.3 Measurement of H2O2 concentration 
I prepared FOX-2 reagent (Nourooz-Zadeh 1999) by dissolving xylenol orange and 
ammonium ferrous sulfate in 250 mM H2SO4 to final concentrations of 1 and 2.5 mM, 
respectively. One volume of this concentrated reagent was added to 9 volumes of HPLC 
grade methanol containing 4.4 mM BHT (butylated hydroxytoluene) to make the working 
reagent which comprised of 250 µM ammonium ferrous sulfate, 100 µM xylenol orange, 
25 mM H2SO4, and 4 mM BHT in 90% v/v methanol. A mixture containing 100 µL of 
sample and 900 µL of FOX-2 reagent was incubated at room temperature for 30 min and 
then the absorbance at 560 nm was measured. The working reagent has an extinction 
coefficient of 4.3xl04 M-1 cm-1 for hydroperoxide. The FOX-2 reagent was prepared in 
bulk and stored in the dark at 4 ºC (good for 6 months). The reagent was calibrated with 
known concentrations of H2O2 before each use. 
5.1.4 Scanning electron microscope (SEM)  
 The SEM in the Physics Department was used to follow the degradation of the 
SWNTs. Samples (250 µL) of CPO treated SWNTs were centrifuged (3400 rpm) and then 
the supernatant was decanted off. The pellet of SWNTs was washed with water twice and 
ethanol three times. For SEM sample preparation, the SWNTs were resuspended in 
approximately 1 mL of N,N-dimethylformamide (DMF) via sonication.  
5.2 Results and discussion 
 Another possible application for CPO is the catalytic biodegradation of hazardous 
waste, especially aromatic substrates, which represent a difficult task for many 
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biodegradation reagents. Given the recent surge in nanowaste, single wall nanotubes 
(SWNTs) represented an ideal target. Another peroxidase, horseradish peroxidase (HRP), 
was recently shown to catalytically degrade SWNTs (Allen, Kichambare et al. 2008). 
The degradation of SWNTs at pH 3 and 5 in the presence of 80 µM H2O2 and CPO 
was evaluated by SEM. However, no significant change in the morphology of the 
SWNTs was detected, suggesting that CPO has little or no effect on the degradation of 
SWNTs under these conditions. Some SEM images are shown below:  
 
A. B. 
 
Figure 5.1 SEM images of SWNTs treated with CPO for 8 weeks. A. pH=3; B. pH=5 
 
5.3 Conclusion 
Unlike HRP, which facilitate the degradation of SWNTs in vitro, CPO seems have 
no effect on their degradation. This may due to the structure and mechanism differences 
of these two enzymes: HRP has a more open active site, and produces reactive oxygen 
species (ROS) during its catalytic cycle while CPO has restricted access to its activity 
site, and does not generate ROS during its catalytic cycle, except for during some 
halogenation reactions. Thus, the ROS produced during the catalytic cycle of HRP may 
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be responsible for the degradation of the SWNTs. Therefore, in the presence of high 
halide concentrations, CPO might facilitate the degradation of SWNTs. 
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Chapter VI 
Perspectives 
 For rCPO expression, a detailed analysis can be done to determine which factors 
affecting the production yield of heme-proteins, such as the copy number of the gene, the 
level of transcription of mRNA, the ratio of apo to holo secreted protein. Co-expressing 
with foldases, molecular chaperones can be done as well, to see if they could help to 
increase production yield of rCPO further. 
The production of partially deuterated -rCPO can be attempted by letting the host 
strain growing in culture media made from D2O. NMR spectrum of deuterated rCPO 
should be less complex than that of its fully protonated analog and offers the possibility 
of assigning additional resonances with concomitant structural information.  
 The dramatic catalytic behavioral changes of the F103A mutant suggest that not only 
the major amino acids, which actually take part in the catalysis, but also that the distal 
heme microenvironment plays an important in regulating catalytic behavior. Additional 
mutations of amino acids close to the heme center should be constructed and expressed, 
based on the current hypothesis. Targets should include V182 and F186. 
 The structure of F103A should be elucidated so that the kinetic and ligand binding 
results can be placed in context. Because the enantioselectivity profile changed with the 
F103 to A mutation, other large amino acids in the active site should be mutated to 
alanine as well, such as V182 and F186. Furthermore, mutants that might improve upon 
the enantioselectivity of WT CPO for styrene should also be constructed such as F103V, 
F103Y, and F103W.
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APPENDICES 
Table A1 Primers used to conduct the research in FIU 
Figure B1 Plasmid pCPO3.1-amds sequencing results by primer walking (12.2k bp) 
Figure B2 Map of assistant plasmid pAB4.1. 
APPENDIX A 
Table A1 Primers used to conduct the research in FIU 
Primer name Primer’s sequence 
C29H-anti:  5’-gac tct cgt gct cct CAC cca gct ctg aac gct c-3’ 
C79H-anti:  5’-c aac gcc ttc gtc gtc CAC gag tac gtt act ggc-3’ 
C87H-anti:  5’-gtt act ggc tcc gac CAT ggt gac agc ctt gtc-3’ 
C29H-sense: 5’ -gag cgt tca gag ctg ggt gag cac gag agt-3’ 
C79H-sense: 5’ -gcc agt aac gta ctc gtg gac gac gaa ggc gtt-3’ 
C87H-sense: 5’ -gac aag gct gtc acc atg gtc gga gcc agt aac-3’ 
F103A-anti:  5’-gcc gag ccc cac gct GCC gag cac gac aca tcc -3’ 
F103A-sense: 5’ –gga tgt gtc gtg ctc ggc agc gtg ggg ctc ggc-3’ 
CPO-anti: 5’-ccg gaa ttc aag gtt gcg ggc ctt gtt-3’ 
CPO-sense: 5’ -cgc gga tcc atg ttc aag gtc ctt ccc-3’ 
 
 APPENDIX B  
Figure B1 Plasmid pCPO3.1-amds sequencing results by primer walking (12.2k bp)  
G A G G A C G G A T T T G G T G A A G A G G C G G A G G T C T A A C A T A C T T C A T C A G T G A C 
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C T G G T A T A G A G C A G G A A A A G A A G G A A G A G G C G A A G G A C T C A C C C T C A A C A 
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Figure B2 Map of assistant plasmid pAB4.1. It contains the pyrG selection marker for A. 
niger. The pyrG gene will be enable the transformed strain the ability to grow without 
uridine supplement 
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